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Abstract 
 
The provision of animal health surveillance in Scotland has recently been reviewed, 
identifying the need to optimise surveillance delivery by making use of existing animal 
health data sources and more cost-efficient approaches. The Scottish Centre for Production 
Animal Health and Food Safety (SCPAHFS) receives uneconomic farm animal cases 
referred by first opinion veterinary practitioners who confirm the fitness of each animal for 
transport. Animals are used for teaching and receive full diagnostic work-ups, including 
gross post-mortem examinations; they are a potentially important source of animal health 
data that is already being used for teaching and research, though not yet for surveillance 
purposes.  
 
With the aim to evaluate the usefulness of the SCPAHFS caseload as a source of surveillance 
data four studies are presented. The first study analyses and presents the demographics and 
referral reasons of the animals admitted to the SCPAHFS between January 2006 and 
December 2015. The second study focuses on the 2015 caseload and compares the diagnoses 
reached at the SCPAHFS with the 2014 Veterinary Investigation Diagnosis Analysis 
(VIDA) report. The third study collates additional information from the case files of 51 BVD 
persistently infected (PI) animals, with the aim to evaluate any changes in their clinical 
presentation that may have occurred as a consequence of the launch of the Scottish BVD 
eradication scheme. Finally, the fourth study presents a case study of a BVD outbreak and 
analyses the impact that the eradication scheme had on this particular farm.  
 
Results of the first study show that the SCPAHFS caseload originated from Central and 
South-West Scotland and Northern England and is mainly represented by cattle (64%) and 
sheep (31%), with 5% of pigs, goats and alpacas. These proportions differ from the Scottish 
livestock population and the samples submitted to VIDA. The main reasons for referral of 
cases included digestive (31%), systemic (19%) and respiratory diseases (15%) and a 
proportion of cases were referred without clinical problems (8%). The second study found a 
clear difference between the diagnoses reached at the SCPAHFS and those included in the 
VIDA report. Digestive and respiratory diseases were the most common diagnoses at the 
SCPAHFS, both in cattle and sheep; whereas ‘diagnosis not reached’ and reproductive 
disease were the main categories in VIDA, followed by digestive conditions in third place. 
Results of the third study showed that more farmers mentioned BVD in the history of cases 
admitted after the start of the scheme. Animals PI with BVD virus (BVDV) admitted after 
the start of the scheme tended to be younger and presented with less clinical disease. In those 
that presented clinical signs, respiratory disease was the most common finding. In addition, 
no cases of mucosal disease (MD) have been diagnosed at the SCPAHFS since 2010. 
 
Any source of passive surveillance is exposed to a degree of bias. At the SCPAHFS cases 
are biased towards chronic, uneconomic conditions. However, results of the presented 
studies indicate that the SCPAHFS caseload represents a portion of the cattle and sheep 
population that are not captured by the VIDA system. This could potentially act as a 
complimentary source of surveillance data. Additionally, the SCPAHFS caseload could also 
contribute with information on endemic conditions. Results of the third and fourth study 
confirm the success of the Scottish BVD eradication scheme, as BVD PI cattle appear to be 
identified and removed at earlier ages, before clinical disease, reducing their contribution to 
transmission of disease and the chances to develop clinical disease. 
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1. Introduction 
 
 
1.1. Animal Health Surveillance 
 
 
1.1.1. Introduction 
 
The term ‘surveillance’ derives from the French verb ‘surveiller’ (Hoad, 2003) and has its 
origins in the French Revolution, when ‘surveillance committees’ were organised to monitor 
the revolutionaries’ activities and act if necessary (Salman, 2003). This was an example of 
surveillance as we know it today; however evidence of actions related to surveillance date 
from as early as the 14th century, e.g. during the Black Death plague detection and control 
measures were applied to control the spread of the disease (Declich & Carter, 1994). Much 
progress has been made since the first attempts to monitor and control diseases and numerous 
definitions have been proposed to describe surveillance. The World Health Organisation 
defined public health surveillance as ‘the continuous, systematic collection, analysis and 
interpretation of health-related data needed for the planning, implementation, and evaluation 
of public health practice’ (World Health Organisation, 2012). In the animal health field, the 
World Organisation for Animal Health (OIE) defined surveillance in a very similar manner: 
‘the systematic ongoing collection, collation, and analysis of information related to animal 
health and the timely dissemination of information so that action can be taken’ (World 
Organisation for Animal Health, 2015). More recently, in the 1st International Conference 
on Animal Health Surveillance (ICAHS) held in 2011, a group of international experts 
agreed on a more detailed definition of animal health surveillance: ‘the systemic 
measurement, collection, collation, analysis, interpretation, and timely dissemination of 
animal health and welfare data from defined populations. These data are essential for 
describing the health-hazard occurrence and to contribute to the planning, implementation, 
and evaluation of risk-mitigation actions’ (Hoinville et al., 2013).  As stated by the 
definitions, surveillance involves not only the processing and analysis of data but also 
planned actions to be taken as a result of the interpretation of the analysis results. This 
differentiates surveillance from monitoring, which includes the same processes as 
surveillance, without the planned measures. 
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Animal health surveillance provides benefits at an economic, political, social and scientific 
level. Surveillance is essential to protect the animals’ health and welfare, but also public 
health by preventing zoonosis and food-borne diseases. It allows demonstration of freedom 
from specific diseases, which is necessary to guarantee international trade. Surveillance is 
also the tool to detect emerging or re-emerging conditions and react against these. It provides 
a better understanding of the prevalence and distribution of endemic conditions and allows 
planning of future research and control programmes (Department for Environment Food and 
Rural Affairs, 2003; The Scottish Government, 2011). Emerging threats to human and 
animal health have been a constant in history (e.g. Bovine Spongiform Encephalopathy 
(BSE), Ebola, Zika virus) and there is general agreement that these will continue arising, 
driven by changing demographics, climate and ecosystems and the continuous increase in 
international commerce and animal trade  (Morens et al., 2004; Baize et al., 2014; Moutou 
and Pastoret, 2015; Chang et al., 2016). At the same time, the science of communication and 
information technology is quickly progressing and this is allowing better and faster data 
management and analysis. In this context of continuous change and challenge, animal health 
surveillance needs to be constantly adapting. 
 
The first part of this literature review will focus on the structure of surveillance systems, the 
different sources available to obtain animal health data, the challenges in collating and 
integrating these data and the organisation and delivery of surveillance in the UK and 
Scotland.  
 
 
1.1.2. Components of surveillance systems 
 
Surveillance systems are the practical application of surveillance (World Organisation for 
Animal Health, 2016a). Several authors have proposed various attributes or components that 
describe a surveillance system (Doherr and Audige, 2001; European Centre for Disease 
Prevention Control, 2014). These include: the surveillance objective, the disease/s and 
population under surveillance, the geographical area covered, the type of data collected, the 
data sources and collection methods, the collation processes, the analytical methods, the 
dissemination of results and the evaluation of the system. The latter is a concept that has 
gained importance in recent years. Evaluations of surveillance systems, in terms of 
20 
  
 
 
 
performance and economic costs, are currently not consistently performed, but these are 
important to ensure that systems are fit for purpose and that resources are used in the most 
efficient way (Drewe et al., 2013).  
 
Regarding the objectives of surveillance systems, the most common aims are to detect the 
incursion of exotic, emerging and re-emerging conditions,  to monitor changes in endemic 
conditions and to demonstrate freedom from disease (Doherr and Audige, 2001; Thrusfield, 
2005). Systems may be applied at a regional, national or international level and they can 
focus on one or multiple conditions. Although diseases are the focus of most surveillance 
systems, these can also be designed to monitor other variables, e.g. risk factors for certain 
diseases (Declich and Carter, 1994; Doherr and Audige, 2001; Häsler et al., 2014).  
 
 
1.1.2.1. Data collection 
 
When planning or designing a surveillance system, it is necessary to establish a case 
definition for each disease or condition under surveillance. Case definitions allow 
classification of diagnoses in a uniform and clear way, to be able to count their occurrence 
and facilitate the analysis and interpretation of results (Declich and Carter, 1994; Weigler, 
2001; European Centre for Disease Prevention Control, 2014). Definitions may consider 
clinical findings, laboratory test results or post-mortem (PM) lesions to define a diagnosis 
and they can also include definitions for confirmed and suspected cases of disease (Declich 
and Carter, 1994). 
 
Animal owners, farmers, stakeholders, veterinary practitioners, diagnostic laboratories and 
government authorities are all involved in the collection of data for surveillance purposes. 
According to the way data are obtained, surveillance systems have typically been classified 
as ‘active’ or ‘passive’ (Hoinville et al., 2013). Active surveillance systems are those where 
data collection is started by the investigator or institution. In other words, the decision to 
investigate a disease is made at a central level. Mandatory surveillance of notifiable diseases 
is usually performed through active surveillance, e.g, testing for tuberculosis and brucellosis. 
The Scottish BVD Eradication Scheme, which in 2013 started its compulsory annual testing 
(The Scottish Government, 2015a), is another example of an active surveillance campaign. 
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In contrast, passive surveillance systems rely on the voluntary reporting of clinical cases by 
observers at a field level; this is often farmers and veterinarians. In the UK, the non-statutory 
surveillance carried out by the Animal and Plant Health Agency (APHA) and Scotland’s 
Rural College (SRUC) laboratories is an example of a passive surveillance system. Active 
surveillance is usually good to estimate the prevalence of a disease in a region or to 
demonstrate freedom from disease, although it is associated with higher costs; whereas 
passive surveillance can be more cost-effective and better for detecting new conditions and 
changing trends in endemic diseases (Doherr and Audige, 2001; The Scottish Government, 
2011). In addition to ‘active’ and ‘passive’, many terms are used to describe different and 
new surveillance systems (Hoinville et al., 2013). In England and Wales, the terms 
‘scanning’ and ‘targeted surveillance’ are used to describe passive and active surveillance 
activities, respectively (Animal and Plant Health Agency, 2014b).  
 
In the animal health field, data for surveillance purposes can be obtained from a great variety 
of sources. These have been reviewed by various authors (Declich and Carter, 1994; 
Thrusfield, 2005; The Scottish Government, 2011; Gates et al., 2015). In the UK, in addition 
to active surveillance campaigns for notifiable diseases, the main source of surveillance data 
is the testing carried out by national government-subsidised laboratories. However, farmers 
and veterinary practitioners may also submit samples to private centres. At the same time, 
private livestock health schemes are active surveillance campaigns that generate 
considerable amounts of animal data regarding particular diseases (Drewe et al., 2014). The 
potential usefulness of private laboratory and health scheme data in  surveillance has been 
recognised (The Scottish Government, 2011), however they are not currently included in the 
national UK surveillance system. Data privacy and management constraints are two of the 
factors that complicate the collation of these sources into a national system (Velasova et al., 
2015).  
 
Not all cases seen by first opinion practitioners are submitted to laboratories. First opinion 
veterinarians may diagnose conditions based on obvious clinical signs (e.g. displaced 
abomasum) and these cases rarely get reported to national laboratories. Veterinary practices 
keep records of the patients seen, visits made to farms and drugs sold to clients that represent 
another important source of animal health data. Syndromic surveillance initiatives – a 
relatively new methodology that focuses on non-specific signs (e.g. clinical signs, mortality) 
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rather than diagnoses for early detection of new, emerging or re-emerging conditions (Dupuy 
et al., 2013), have looked into the potential of using clinical records in surveillance systems. 
In the small animal field, the SAVSNET – driven by the British Small Animal Veterinary 
Association (BSAVA) and the University of Liverpool (University of Liverpool, 2016), and 
VetCompass projects – a collaboration of the Royal Veterinary College (RVC) and the 
universities of Syndey, Cambridge, Sussex and Lincoln (Royal Veterinary College, 2016), 
are gathering data from private first opinion practices across the UK and have published 
various articles regarding the epidemiology and demographics of common conditions of 
cats, dogs and some exotic species (Jones et al., 2014; O’Neill et al., 2014b; O’Neill et al., 
2016). Traditionally, apart from the few OIE-listed conditions that affect pets (e.g. rabies, 
leishmaniasis and leptospirosis), due to their lower economic and public health impact 
surveillance of companion animal diseases has been marginal compared to livestock health. 
Therefore, syndromic surveillance initiatives are beneficial to this field, especially in an 
environment where travelling pets and exotic or wild pets are becoming increasingly 
common (Reaser et al., 2008; Moore and Lund, 2009). Currently, neither SAVSNET nor 
VetCompass include clinical records from farm animal practices, although VetCompass is 
aiming to include equine practices in their database (Royal Veterinary College, 2015). 
Equine syndromic surveillance is already in application in other parts of the world (Ruple-
Czerniak et al., 2014). In the United States of America (USA), the Veterinary Medical 
Databases (VMDB) is a system has been collecting data from veterinary college teaching 
hospitals since the 1960s (The Veterinary Medical Databases, 2014). Although the main 
focus is companion animals, the database has also provided data for epidemiological studies 
in cattle medicine (Constable et al., 1992; Mavangira et al., 2008). In France, New Zealand 
and the USA, attempts have been made to use databases to collate data from first opinion 
farm animal practitioners (Vourc’h et al., 2006); however, the author could not find evidence 
that these are still in use. Similar initiatives exist in other countries, mainly in the syndromic 
surveillance field. A summary of initiatives and systems that use clinical records as a source 
of data can be found in a review by Dupuy and others (Dupuy et al., 2013).  
 
Drug sales and data from pharmaceutical companies can also provide information to be used 
for surveillance purposes. In Denmark, Sweden, Norway and Finland farm animal veterinary 
treatments are recorded in a national disease recording system. However poor data 
completeness complicated the use of these records for surveillance purposes (Mörk et al., 
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2010; Lind et al., 2012).  In Denmark, surveillance of antimicrobial resistance uses 
VETSTAT, a relational database that collates data regarding the use of drugs at a farm level 
(Stege et al., 2003). 
 
Abattoirs process large numbers of carcasses every day. Live animals are examined on 
arrival and inspections are performed on the carcasses through processing to detect disease. 
The results of these inspections are already recorded in most abattoirs; however, unless there 
is suspicion of a notifiable condition, lesions identified during ante- and post-mortem 
inspections are not reported at a central level (The Scottish Government, 2011). Meat 
inspection has the potential to add information about conditions that may not be reported to 
national surveillance laboratories, especially those that are subclinical and have been missed 
by the farmer and veterinarian but present lesions at PM (Alton et al., 2012; Stärk et al., 
2014; Vial and Reist, 2014). Condemnation rates at abattoirs do get reported and their 
monitoring has been shown to have potential uses in surveillance systems (Alton et al., 2012; 
Vial and Reist, 2014). Abattoirs receive healthy animals that are intended for human 
consumption, whereas fallen stock collection centres receive diseased animals that die or are 
euthanased on farm and that have not been submitted for PM examinations, therefore these 
centres could potentially identify conditions that are missed at DSC or VI centres. The main 
inconvenience in gathering surveillance data from fallen stock centres is the fact that PM 
examinations are not routinely performed in their facilities, which would require a 
remarkable investment of time and resources (Lovatt and Strugnell, 2013). In Europe, cattle 
mortality and movements have to be declared and registered. In the UK, this is done through 
the Cattle Tracing System (CTS) online database (British Cattle Movement Service, 2016). 
The final report of the review of surveillance in Scotland recommended the incorporation of 
CTS data into the surveillance system (The Scottish Government, 2011). Recent studies have 
found that monitoring mortality numbers could be useful for early detection of disease 
outbreaks (Perrin et al., 2012; Struchen et al., 2015; Alba et al., 2015). In addition, 
monitoring animal movements can help in predicting the spread of diseases and identify 
those areas more susceptible to outbreaks (Green and Kao, 2007).  
 
In recent years, European legislation has driven changes in husbandry practices that may 
have an impact on the way diseases spread between populations, e.g. ban on individual 
housing of pregnant sows in 2013 (Maes et al., 2016) and removal of the milk quota in 2015 
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(Boere et al., 2015; Groeneveld et al., 2016). In addition, before diseases are clinically 
noticeable they may cause decreases in milk production or affect the animals’ reproductive 
function. Most farmers, especially in the dairy industry, use data recording systems to 
monitor their animals’ performance. Therefore, these can provide useful data with potential 
to be used for surveillance purposes (Madouasse et al., 2014; Marceau et al., 2014). In 
Denmark, the Danish cattle database centralises information regarding diseases, production, 
reproduction and other factors related to the dairy industry and has been used for surveillance 
purposes since 1989 (Bartlett et al., 2001). In Scotland, the Animal Health Planning System 
(SAHPS) and the Beef Efficency Scheme (BES) are two examples of initiatives that could 
provide similar data from the cattle and sheep sectors. The SAHPS is a web-based system 
used mainly by sheep and beef farmers. It records production and disease data and allows 
comparison of performance between farms (Scotland’s Rural College, 2016a). The BES is a 
five-year project that aims to improve the economic and environmental efficiency of beef 
suckler herds (The Scottish Government, 2016a). Farmers that take part in the scheme are 
required to record calving data, including the calving ease, the calf vigour and calf mortality 
and, as an incentive, they are offered a payment of £32 per calf (The Scottish Government, 
2016c). In addition to paper records, these data have to be entered into a database designed 
for the scheme. This database is hosted on the ScotEID webpage, which also hosts the 
Scottish BVD Eradication Scheme database created in 2013 (ScotEID, 2016). In the dairy 
industry, the Cattle Information System (CIS) is another web based recording system that 
collates performance and disease data and produces a wide variety of reports for farmers and 
veterinarians (Cattle Information Service, 2016). The fact that data like those generated by 
the SAHPS, BES and CIS are already available in electronic format should be favourable 
for them being useful to evaluate the situation and monitor changes in the sector.  
 
 
1.1.2.2. Data collation 
 
Data for surveillance purposes can be obtained from many sources: however, various factors 
complicate the collation of these data into a common surveillance system. One of the main 
constraints is that, in most cases, different institutions and providers use different 
terminology and diagnoses that are often not based on pre-established case definitions (Stark 
and Nevel, 2009). Unifying the language and terms is key to allow communication and 
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transfer of data between sources. Human medicine is years ahead of veterinary in the use of 
coded terminology and diagnoses. The largest terminology catalogue in human health is the 
Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT), which has been in 
use for over 40 years. The SNOMED CT catalogue also includes veterinary terms and is 
used by the VMDB (The Veterinary Medical Databases, 2014). Examples of standardised 
terminology specific to veterinary medicine are scarce. In the UK, the Veterinary 
Nomenclature (VeNom) codes were initially derived from SNOMED CT with the aim to 
create a terminology that was more accessible to veterinary practitioners (VeNom Coding 
Group, 2009). These are being used by the VetCompass project (O’Neill et al., 2014a). 
However, VeNom does not include pathologies that are specific to farm animals such as 
abomasal displacements. There are currently no standardised coding systems specific to 
production animals. The VIDA system diagnostic codes were based on the terminology 
developed by the University of Michigan and the National Cancer Institute in America 
(Hugh-Jones et al., 1969) and these have been regularly reviewed and updated since the 
database was created (Gibbens et al., 2008).  
 
Another constraint to the collation of data from various sources is differences between the 
data recording methods used by different providers. Although the use of data management 
software is increasing, different systems are not inter-connected and some providers still 
record data in paper format (Stark and Nevel, 2009). In addition, although systems like the 
CIS or SAHPS are web based and all the users record data in the same platform, farmers 
may make different uses of the system and record data in different ways, e.g. some dairy 
farmers may not record subclinical mastitis in the CIS and other may record subclinical cows 
with high somatic cell counts as cases of clinical mastitis. In the UK, a study found that the 
potential usefulness of various health schemes and production recording systems for 
surveillance purposes was affected by remarkable differences between the data management 
systems used (Velasova et al., 2015). In 2015 the Agriculture & Horticulture Development 
Board (AHDB) launched the Data Hub Project with the aim to facilitate data exchange 
between the Government and private databases, initially focusing on animal diseases, but 
with plans to expand to other types of production data (Agriculture & Horticulture 
Development Board, 2015). The Rapid Analysis and Detection of Animal-related Risks 
(RADAR) database is an example of a system that collates surveillance data from multiple 
sources in the UK. These include data from the Cattle Tracing System (CTS), the APHA VI 
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centres results and the brucellosis and Salmonella testing campaigns (Lysons et al., 2007). 
However, information about access through this system and the currency of the data are 
difficult to find. 
 
 
1.1.2.3. Bias in surveillance data 
 
In addition to the obstacles to collate data from various sources, bias is a common factor 
affecting surveillance data quality. Bias is defined as “an error in the conception and design 
of a study ― or in the collection, analysis, interpretation, reporting, publication, or review 
of data ― leading to results or conclusions that are systematically (as opposed to randomly) 
different from truth” (Porta, 2008). Any surveillance system is exposed to a degree of bias. 
Although most active surveillance systems depart from planned data collections, based on 
sample calculations that should guarantee that the estimates are truly representative of the 
general population (Salman, 2003), sampling errors or bias still occur in some cases. For 
example, risk based surveillance efforts are purposely skewed towards groups of animals 
that are thought to be more likely to suffer certain diseases (Thrusfield, 2005). In addition, 
test inaccuracies due to low sensitivity and specificity can also lead to inaccurate results 
(Haut and Provost, 2011). However, the nature of data gathered for passive surveillance is 
always associated with a higher degree of bias. Passive systems rely on the willingness of 
farmers and first opinion veterinarians to submit cases or samples and this can be affected 
by a multitude of factors, leading to selection bias (Robinson et al., 2012). Underreporting 
is a common problem in passive surveillance and incentives and subsidised testing are aimed 
at increasing the submission rates to national surveillance laboratories (Zurbrigg and Van 
den Borre, 2013; Struchen et al., 2015). Disease awareness also has an impact on submission 
of cases to surveillance systems. Severe diseases, those that have higher mortality rates, that 
affect more animals or unknown conditions, are more likely to be reported; whereas those 
endemic, common conditions that can cause less apparent losses or that may be diagnosed 
by the first opinion veterinarian (e.g. displaced abomasum, lameness, ringworm) are usually 
underreported (Declich and Carter, 1994; Watson et al., 2008; Animal and Plant Health 
Agency, 2014d). The value of the animal and the distance to the laboratory or referral centre 
are other factors that can affect submission rates (Watson et al., 2008; Bartlett et al., 2010). 
It has been found that farmers participating in health schemes are more likely to submit 
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samples to DSC or VI centres, since they usually have a keen interest in knowing what 
diseases are affecting their herds or flocks (Watson et al., 2008). Data obtained from certain 
sources are also biased per se, for example, animals submitted to abattoirs represent a healthy 
sample of the population, whereas fallen stock collection services receive diseased, 
uneconomic individuals. Veterinary hospitals are exposed to referral bias, due to the fact that 
certain conditions are dealt with by first opinion practitioners and they receive those that 
need specialised care (Bartlett et al., 2010). Misclassification of diagnoses can also affect 
surveillance data, when different diagnostic methods are used and especially when no case 
definitions are established, since two clinicians may reach different conclusions based on a 
series of clinical signs. In addition, disease prevalence and incidence can usually only be 
calculated with data collected through active methodologies, since they provide details about 
the sampled population (Doherr and Audige, 2001), and these are rarely available in passive 
surveillance datasets.  
 
 
1.1.2.4. Integration of results 
 
Data analysis is the essential process that allows interpretation of surveillance data. 
Depending on the system and type of data collected, various analytical methods can be used. 
These include basic statistics (statistical tests and equations), regression models including 
time series, spatial epidemiology and simulation modelling, among others (Höhle et al., 
2009; Rodríguez-Prieto et al., 2014). To detect changes in disease trends, the analysis of 
surveillance data usually involves comparing the results obtained with previous observations 
made in the same region or between neighbouring areas (Declich and Carter, 1994). As an 
example, in the case of the VIDA database, quarterly data are compared to the previous 
quarter and to the mean in the same quarter of previous years (Gibbens et al., 2008) 
 
 
1.1.2.5. Communication of results 
 
After the analysis of surveillance data, sharing its results is key to fulfil the ultimate aim of 
a surveillance system: to produce information that helps institutions, stakeholders, veterinary 
practitioners and farmers make decisions regarding the prevention and control of animal 
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disease (Department for Environment Food and Rural Affairs, 2003). In passive surveillance 
systems, where the reporting by farmers and veterinarians is essential for data collection, 
communication and feedback helps raise awareness and improves the engagement and 
participation in the system (Robinson et al., 2012). 
 
Surveillance results need to be presented in a clear way that helps the reader to understand 
and interpret the data. Reports should include tables, graphs and/or figures and be 
accompanied by text interpreting the results. However, the format of the report may vary 
based on the audience it is aimed at, e.g. general public, farmers, veterinarians or government 
members. Nowadays, most reports are shared via email or made available online, although 
in some cases data are still published in paper format. The frequency of reporting usually 
varies from monthly or quarterly to annual reports (Declich and Carter, 1994). 
 
The OIE collates results from surveillance of listed conditions around the world. These are 
used to present the worldwide prevalence and distribution of these conditions in maps and 
reports through the World Animal Health Information Database (WAHID) interface (World 
Organisation for Animal Health, 2013). This is an interactive webpage that includes weekly 
reports for new and ongoing disease outbreaks at the country level. Maps for outbreaks and 
the country status regarding a specific disease are also available. However, data are only 
available grouped by six-month periods, they are often not up-to-date and information is 
missing for many countries. In the UK, an annual report is produced from the VIDA database 
(Animal and Plant Health Agency, 2015c), which can be freely accessed through the APHA 
website. The report presents the monthly diagnoses reached at the APHA VIC and SRUC 
DSC during that year and the yearly diagnoses for the last seven years. However, it is usually 
published in September/October of the following year, which limits the value it has. These 
are presented in a table format and some accompanying graphs and figures in an additional 
document (Animal and Plant Health Agency, 2014d); however, there is no text 
accompanying the data, which makes the result interpretation more difficult for the public. 
However, the report includes the total number of samples received per year, which allows 
the public to make their own calculations, and additional data can be retrieved from VIDA 
by contacting the AHPA. In addition to the annual VIDA report, in England and Wales, the 
APHA publishes a monthly report that highlights the most commonly reported or interesting 
conditions diagnosed at their VIC  (Animal and Plant Health Agency, 2015a), which 
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eventually includes graphs. The same report is published in the Veterinary Record (Animal 
and Plant Health Agency, 2015b). In January 2016, after changes were made to the 
organisation of surveillance delivery in England and Wales (see section 1.1.3.2.), the report’s 
format was updated to incorporate surveillance information obtained by sources outside the 
Government (Animal and Plant Health Agency, 2016). The new report also includes a 
section on international disease monitoring and a section dedicated to topics raised by the 
Veterinary Risk Group (VRG), a cross-government group that was created in 2009 in 
response to the need to include emerging threats in the existing UK surveillance system (Del 
Rio Vilas et al., 2013; Anon, 2016). A monthly report produced by the Scottish Agricultural 
College (SAC) Consulting Veterinary Services aimed at veterinary practitioners can be 
found in the Veterinary Record (SAC Consulting Veterinary Services, 2015) and in the 
SRUC’s website (Scotland’s Rural College, 2016b). The format is very similar to the old 
APHA’s report and only includes descriptions of cases. The total numbers and data regarding 
all the pathologies diagnosed at the DSC are not usually provided. The SAC also publishes 
a twice-yearly surveillance newsletter aimed at livestock keepers which includes short 
summaries on endemic and emerging conditions, accompanied by pictures that may help to 
improve reporting (Scotland’s Rural College, 2016c). However, an equivalent of the VIDA 
report with conditions diagnosed in Scotland is not available. In Northern Ireland, regular 
summaries are also published in the Veterinary Record (Agri-Food and Biosciences Institute, 
2015); however, the results from passive surveillance are not reported into the VIDA system 
but published in the All Ireland annual report (Department of Agriculture Food and the 
Marine and Agri-Food and Biosciences Institute, 2015), which also includes results from 
surveillance activities in the Republic of Ireland. In this case, although the report is annual, 
it is a longer document that presents the results of surveillance in graphs and figures 
accompanied by written summaries and covers several conditions, including anthelmintic 
and antimicrobial resistance. The report includes pictures of PM findings, which may be 
useful to help veterinary practitioners in identifying pathologies when performing field PM 
examinations. In Australia, the National Animal Health Information System (NAHIS) which 
integrates data from multiple surveillance programmes in the country, publishes extensive 
quarterly and annual reports that present statistics accompanied by figures, graphs, maps and 
provides a good interpretation of the results (Animal Health Australia, 2016b; Animal Health 
Australia, 2016a). In addition to official reports published by subsidised laboratories, 
scientific articles in peer-reviewed journals are another common way of reporting 
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surveillance data. An example of these are the BVD prevalence studies performed before the 
start of the Scottish BVD Eradication Scheme (Brülisauer et al., 2010; Humphry et al., 2012) 
 
 
1.1.3. The delivery of animal health surveillance 
 
 
1.1.3.1. International examples 
 
The principles of surveillance are the same around the world; however, different countries 
may adopt different approaches to organise their surveillance systems. One of the main 
differences is how surveillance is funded. The majority of surveillance systems across 
European countries are publicly funded; however, some base their surveillance only on 
private systems (Häsler et al., 2014). The latter is the case for Denmark, where it was decided 
that, due to the small amount of imports the risk of introducing new diseases was very low 
and it did not justify a government funded laboratory (The Scottish Government, 2011). The 
organisation of laboratories and institutions performing surveillance activities also varies 
across the world. In the USA and Canada, surveillance for non-notifiable conditions relies 
on state and provincial organisations, but a national network coordinates the surveillance 
activities carried out by the different centres (Kloeze et al., 2010; United States Department 
of Agriculture, 2016). In Finland, four government-funded laboratories are localised in the 
areas with highest livestock density (The Scottish Government, 2011), whereas in The 
Netherlands only one laboratory is responsible for the testing of samples that generate 
surveillance data. The latter is located in the geographical centre of the country, which has 
been shown to not affect case submission rates. Animal health surveillance there is 
supplemented by a telephone helpdesk that offers advice to veterinarians and may start 
follow-up investigations when needed (GD Animal Health, 2014). This system allowed the 
early detection of Bluetongue virus serotype 8 and Schmallenberg virus (van Wuijckhuise 
et al., 2006; Elbers et al., 2012). In addition, The Netherlands also collects data from many 
other sources including production and husbandry data and abattoirs (GD Animal Health, 
2014). This is also the case in the Scandinavian countries, where data regarding drug usage 
is used especially for the monitoring of antimicrobial resistance (Stege et al., 2003). 
 
31 
  
 
 
 
1.1.3.2. The United Kingdom system 
 
Examples of how surveillance is organised in the UK have already been given in previous 
sections. To finish with the surveillance part of this literature review, an overview of the 
delivery of surveillance in the UK and Scotland is given in this section, with emphasis on 
the recent reviews and changes in its organisation.  
 
In addition to active or targeted surveillance campaigns for notifiable diseases, the main 
source of surveillance in the UK is the publicly subsidised testing performed at the APHA 
VI centres in England and Wales, the SRUC DSC in Scotland and the AFBI laboratories in 
Northern Ireland. Private laboratories and livestock health schemes represent additional 
surveillance initiatives, although due to privacy and commercial reasons, very few data are 
publicly available (Drewe et al., 2014). In 2012 it was calculated that approximately 14% of 
cattle herds were included in the Cattle Health Certification Standards (CHeCS) that 
regulates health schemes across the UK and the Republic of Ireland (Brigstocke, 2012). 
These include important diseases like BVD and Johne’s disease and represent a missed 
opportunity to benefit from information regarding the prevalence of these conditions in the 
UK.  Overall, cattle are the focus of most surveillance activities in the UK, involving nearly 
94% of the public and private surveillance expenditure. By contrast, sheep represent up to 
70% of the British livestock population and only receive 2% of the surveillance funds 
(Drewe et al., 2014; The Scottish Government, 2016b). 
 
The diagnoses reached at the VI centres and DSC are collated in the VIDA database. The 
VIDA system was developed in 1967 (Hugh-Jones et al., 1969) and re-designed in 1973 
(Hall et al., 1980). This was the first veterinary diagnostic centralised recording system in 
the UK. The VIDA codes were adapted from the Veterinary Medical Data Processing 
Scheme (VMDP) created by the US National Cancer Institute and have been periodically 
reviewed since then (Hugh-Jones et al., 1969; Hall et al., 1980). The individual diagnoses 
are grouped under nine body system groups which have been in use since VIDA was 
developed (Hugh-Jones et al., 1969). Initially, information was stored using card tabulators, 
but these were replaced by computers in the early 70s. Data were analysed annually. The 
main disadvantage of the VIDA database was that a category or detection system was not 
included for unknown emerging conditions. Therefore, after the bovine spongiform 
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encephalopathy (BSE) crisis, the system was reviewed in 1999. A new database called 
FarmFile was created to record additional information (Gibbens et al., 2008). Since 2004 
data are analysed every four months and syndromes (diseases grouped by systems) and 
‘diagnosis not reached’ (DNR) cases are analysed to detect any clusters that may suggest 
emergence of new or re-emergence of existing conditions (Gibbens et al., 2008). Bovine 
neonatal pancytopenia (‘bleeding calf syndrome’) and Schmallenberg virus are two 
examples of emerging diseases whose incursions in the UK were first detected by the APHA 
network of VI centres  (Veterinary Laboratories Agency, 2009; Anon, 2012). During the 
first years of the database, about 150,000 samples were processed each year (Hall et al., 
1980). Between 43,000 and 63,000 samples have been submitted to the database over the 
last eight years, with a progressive decrease in numbers since 2012 (Animal and Plant Health 
Agency, 2015c).  
 
The first national laboratories in the UK were established in 1922 and since then the delivery 
of surveillance and the organisation of the laboratories have undergone many reviews 
(Bradley, 2000; The Scottish Government, 2011). After the BSE and FMD crises, the whole 
UK surveillance strategy was reconsidered in 2003 (Department for Environment Food and 
Rural Affairs, 2003). As a consequence, both the delivery of surveillance in England and 
Wales and Scotland were reviewed in 2012 and 2011 respectively (The Scottish 
Government, 2011; Surveillance Advisory Group, 2012). After the recommendations made 
by both reports, changes to the organisation of surveillance are still being debated. The need 
for more cost-effective approaches to veterinary surveillance was identified in both reviews. 
In England and Wales the APHA funding has been reduced from £10.2 to 7.2 million 
between 2010 and 2015 and in 2014 the first changes were applied to the delivery of PM 
examinations, with the closure of eight PM facilities. The provision of PM examinations was 
then supplemented by the RVC, the University of Bristol, the University of Surrey and the 
SRUC in North East England (Animal Health and Veterinary Laboratories Agency, 2013). 
A triage of samples has been added to the submission process and only those samples with 
potential use as surveillance material receive subsidised testing (University of Surrey, 2015) 
and a carcass collection service was introduced for those farms located more than one hour 
away from the PM examination facilities (Animal and Plant Health Agency, 2014a). In 
Scotland, an outcome of the 2011 review in Scotland was the creation of a ‘Strategic 
Management Board’ which was established in 2012 and is responsible for advising the 
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Scottish Government in the field of animal health surveillance. The review also 
recommended the closure of SRUC DSC, the centralisation of the laboratory services into 
one facility and the incorporation of existing animal health data streams to the current 
surveillance system (e.g. abattoir and CTS data) (The Scottish Government, 2011). The 
closure of the Inverness and Ayr DSC was discussed. A consultation process took place in 
which it was suggested that the Ayr DSC services could have been transferred to the School 
of Veterinary Medicine of the University of Glasgow. However, after the consultation with 
farmers, veterinarians and stakeholders it was decided to maintain both centres with some 
reorganisation.  
 
The Scottish Centre for Production Animal Health and Food Safety (SCPAHFS) of the 
School of Veterinary Medicine of the University of Glasgow receives uneconomic cases 
donated by farmers and veterinarians in Scotland and Northern England. Animals receive 
full diagnostic work ups, including gross PM examinations and therefore represent an 
important source of animal health data. This data stream could potentially contribute to the 
existing surveillance system in Scotland and one of the aims of this thesis is to assess this 
possibility. 
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1.2. Bovine Viral Diarrhoea Virus 
 
 
1.2.1. Introduction 
 
In 1946, ‘an acute, infectious and contagious disease of cattle’ which caused ‘gastroenteritis 
with severe diarrhoea’ was described for the first time in the United States of America (USA) 
(Olafson et al., 1946) and Canada (Childs, 1946). The disease was later named Bovine Viral 
Diarrhoea (BVD) (Olafson and Rickard, 1947). Over the past 70 years several research 
streams have continuously focused on BVD, which has been recognised as a disease that has 
a large impact on cattle productivity (Bennett et al., 1999; Gunn et al., 2004; Houe, 2003). 
The disease has been widely reviewed (Lanyon et al., 2014; Grooms, 2004; Baker, 1995; 
Brodersen, 2014; Campbell, 2004), new studies are published every year and, although the 
complex pathogenesis of BVD virus (BVDV) is not completely understood yet, many 
countries have applied successful BVD eradication programmes (Valle et al., 2005; Presi et 
al., 2011; Synge et al., 1999; Bitsch et al., 2000; Presi and Heim, 2010). In Scotland, a BVD 
eradication scheme was launched in 2010. By 2015 it was calculated that only 12% of the 
herds were still exposed to BVDV (The Scottish Government, 2016d). The Scottish Centre 
for Production Animal Health and Food Safety (SCPAHFS) has admitted animals 
persistently infected (PI) with BVDV since before the start of the Scottish eradication 
scheme. Currently, BVDV PI animals are still being admitted. Chapter 5 of this thesis 
analyses the evolution of the clinical presentation of PI animals at the SCPAHFS over this 
period and Chapter 6 presents a case study of an outbreak at a Scottish farm during the 
Eradication Scheme. Therefore, general aspects of the disease will be reviewed in this 
section, with focus on its clinical presentation, control and eradication and the current 
situation in Scotland. 
 
 
1.2.2. Aetiology 
 
Bovine Viral Diarrhoea is caused by a virus of the family Flaviviridae, genus Pestivirus. 
Virions of the genus Pestivirus are small (40-60 nm in diameter), spherical, have a single 
strand of RNA and present a lipid envelope that makes them sensitive to most common 
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disinfectants (King et al., 2011). The genus Pestivirus includes four species: Classical Swine 
Fever Virus (CSFV), Border Disease Virus (BDV), Bovine Viral Diarrhoea Virus 1 (BVDV-
1) and Bovine Viral Diarrhoea Virus 2 (BVDV-2). A new group of viruses, known as 
atypical Pestiviruses or Hobi-like viruses, are currently not recognised as an official species 
(Bauermann et al., 2013). The two BVD viruses were typically presented as two genotypes 
of the same species (Ridpath et al., 1994) but these are now recognised as two independent 
species (King et al., 2011). However, the term genotype is still commonly used in the 
literature and both species are divided into multiple subgenotypes (Silveira et al., 2015; Sato 
et al., 2016). Currently, 16 BVDV-1 and three BVDV-2 subgenotypes have been identified 
(BVDV-1a to p  and BVDV-2a to c) (Peterhans et al., 2010). The virus has a high antigenic 
variability, which means that new subgenotypes and strains of BVDV-1 and 2 are constantly 
being discovered (Neill, 2013; Ridpath et al., 2015). 
 
Regardless of the species, BVD viruses present two biotypes, non-cytopathic (ncp) and 
cytopathic (cp). Cytopathic viruses are named after their ability to cause apoptosis of 
cultured cells (Kümmerer et al., 2000). The cytopathic effect is due to a change at the 
molecular level: ncp- BVDV strains express an intact non-structural protein known as NS2-
3, while cp-BVDV isolates have undergone recombination or mutation processes and, in 
addition to NS2-3, they express NS2 and NS3 independently (Kümmerer et al., 2000). The 
marker for the cytopathic effect is NS3. The classification into biotypes has no implications 
on the virulence of the virus, which is dependent on the virus strain (Kelling et al., 2005; 
Glotov et al., 2016). Non-cytopathic strains can cause severe transient BVD infections 
(Peterhans and Schweizer, 2010) and the only time when cp strains are systematically more 
virulent than ncp is when they cause mucosal disease (MD) (see section 1.2.4.4). 
Traditionally, severe BVD outbreaks were always thought to be related to BVDV-2 (Ridpath 
et al., 2006), but these have also been reported in cases where BVDV-1 has been isolated 
(Ridpath et al., 2007; Strong et al., 2015; Glotov et al., 2016).  
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1.2.3. Epidemiology 
 
 
1.2.3.1. Prevalence 
 
In 2005 BVD was included in the World Organisation for Animal Health (OIE) list of cattle 
diseases and infections, although not as a notifiable disease (World Organisation for Animal 
Health, 2016b). The disease is spread worldwide, but the prevalence of BVDV-1 and 2 varies 
across countries. The most prevalent species worldwide is BVDV-1, although BVDV-2 has 
been found to have higher prevalence in America in comparison to other regions (Bolin and 
Ridpath, 1998; Silveira et al., 2015; Workman et al., 2016). Type two BVDV has been 
reported in several European countries (Letellier et al., 2010; Luzzago et al., 2014; Polak et 
al., 2014; Arduriz et al., 2015; Gethmann et al., 2015). In the UK, BVDV-1 is also the most 
common species (Vilček et al., 1999; Booth et al., 2013) and BVDV-2 has been reported 
(Wakeley et al., 2004), but not in recent years (Animal Health and Veterinary Laboratories 
Agency, 2014). Several studies have provided estimates for the overall prevalence of BVDV 
in different countries. In the absence of eradication programmes, the results have shown to 
be very variable with values of 18 to 97% of seropositive herds (Løken et al., 1991; Houe et 
al., 1995; Houe et al., 1999; Saa et al. 2012; Sarrazin et al., 2013; Machado et al., 2015) and 
these values are likely to vary over time (Brülisauer et al., 2010). The prevalence of 
persistently infected (PI) animals, that are key for the transmission of the disease and will be 
further discussed later in this chapter, is also very variable; however, it is estimated that they 
represent less than 2% of the cattle population (Bolin et al., 1985; Houe and Meyling, 1991; 
Houe et al., 1995; Taylor et al., 1995; Sarrazin et al., 2013). 
 
Bovine viral diarrhoea virus can infect species other than cattle, including sheep, goats, deer, 
rabbits, camelids and pigs (Carman et al., 2005; Krametter-Froetscher et al., 2010; Passler 
and Walz, 2010; Tao et al., 2013; Ochirkhuu et al., 2016; Passler et al., 2016). These may 
act as reservoirs of the virus and their importance in the transmission of the disease will be 
discussed in section 1.2.3.3. In the UK, BVDV has been reported in deer (McMartin et al., 
1977), alpacas (Foster et al., 2005) and rabbits (Grant et al., 2015). 
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1.2.3.2. Morbidity and mortality 
 
Overall, BVD is a disease that causes high morbidity and low mortality. In the first reported 
outbreaks,  the morbidity caused by BVDV was calculated at 33-88% and the mortalities 
varied between 4 and 8% (Olafson et al., 1946). Lower values have been described in recent 
years: in a study that followed unvaccinated weaned calves exposed to PI cattle, the 
morbidity rate ranged between 42 and 51%, while the mortality was 1-4.5% (Grooms et al., 
2014). However, if virulent strains are involved, the mortality can reach higer values. In a 
severe outbreak caused by a BVDV-2 strain in Germany, where  most herds were naïve to 
the virus due to the eradication scheme without vaccination, 29.5% of the affected animals 
died (Gethmann et al., 2015).  
 
 
1.2.3.3. Transmission 
 
The virus can be transmitted by direct contact between a naïve and a susceptible animal or 
by indirect contact with fomites. The most frequent route of transmission of BVDV is 
through oro-nasal secretions and naïve animals would go on to develop a transient infection 
(Müller-Doblies et al., 2004). However, if the exposed animal is pregnant, transplacental 
(vertical) transmission of BVDV is key in the epidemiology of the disease. Calves can be 
born persistently infected (PI) with BVDV if they are infected in utero, between 18 and 125 
gestational days, prior to the start of the development of the foetal immune system 
(McClurkin et al., 1984; Grooms, 2004). These PI calves become immunotolerant to the 
virus, they do not recognise it as an external threat and cannot mount an antibody response 
against the virus (Chase, 2013). Animals PI with BVDV shed large quantities of virus in 
their body fluids, including nasal and ocular secretions, milk, urine, faeces, semen and foetal 
fluid and membranes (Houe, 1995), and they are the most important source of infection. The 
role of PI animals is essential for the maintenance of the virus in a population; however, 
transmission of BVDV has also been described in the absence of PI cattle (Moen et al., 
2005). Transiently infected animals (TI) are able to transmit the disease if they contact a 
susceptible animal during the stage of viraemia, which usually lasts between 3 and 12 days 
(Müller-Doblies et al., 2004); however, they are considered epidemiologically less important 
(Niskanen et al., 2002; Lindberg and Houe, 2005; Sarrazin et al., 2014). Self-clearance of 
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BVDV has been described in herds where no PI cattle were present (Ståhl et al., 2008). 
Fomites can also be involved in the transmission of BVDV. Successful transmission of the 
virus has been described after using contaminated farming instruments (Gunn, 1993), 
needles and drug bottles (Gunn, 1993; Niskanen and Lindberg, 2003) and by sharing rectal 
gloves between PI and naïve cows (Lang-Ree et al., 1994). In a severe BVDV outbreak in 
Germany in 2012,  veterinary practitioners were responsible for introducing the disease to at 
least three farms (Gethmann et al., 2015). Within the farm, the virus can survive in slurry for 
three weeks at 5°C (Bøtner and Belsham, 2012) and environments contaminated with 
amniotic and allantoic fluids, especially after the birth of a PI calf, can also be a source of 
infection (Lindberg et al., 2004). Airborne transmission of the virus has been described 
inside housing units or between close units that have air communication (Mars et al., 1999; 
Niskanen and Lindberg, 2003). Flies have been shown to carry the virus, but their role in 
BVD transmission is questionable (Tarry et al., 1991; Gunn, 1993; Chamorro et al., 2011). 
Indirect routes of transmission may become more important towards the end stages of 
eradication programmes (Lindberg and Houe, 2005). 
 
Semen from TI and PI bulls is another source of BVDV. In different studies, when serving 
susceptible heifers with BVDV contaminated semen, only a small number of heifers 
seroconverted, but those that did were able to transmit the disease to other peers that had 
been served with non-contaminated semen and these gave birth to PI calves (Kirkland et al., 
1991; Kirkland et al., 1994; Kirkland et al., 1997; Rikula et al., 2008; Newcomer et al., 
2014). Contaminated frozen semen has been related to severe BVD outbreaks (González 
Altamiranda et al., 2012). In the case of TI bulls, after these have seroconverted, the risk of 
infection is likely to be much lower (Givens et al., 2003). In addition to transient and 
persistent infections, bulls have been reported to be affected by chronic testicular infections 
that will be briefly discussed in section 1.2.4.5. Two bulls have been confirmed to be affected 
by this type of infection in insemination centres (Voges et al., 1998; Newcomer et al., 1998) 
and when their semen was used in seronegative dams, PI calves were born (Niskanen et al., 
2002). The current biosecurity measures and testing protocols applied at insemination 
centres should guarantee that the risk of transmitting the disease from artificial insemination 
is very low, but bulls should be considered when evaluating the risk of introducing the 
disease to the herd, especially in beef systems with natural mating. In the reproduction field, 
the role of infected embryos in the transmission of the disease has also been studied. 
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Embryos can be infected with BVDV when fertilised with infected semen or retrieved from 
PI cows; however, various studies have shown that the standardised washing processes 
greatly reduces the risk of transmission (Brock et al., 1997; Bielanski et al., 2013). 
 
Sheep, goats and deer have been shown to be able to transmit BVDV to cattle in experimental 
and natural conditions (Uttenthal et al., 2005; Bachofen et al., 2013; Braun et al., 2014). This 
could have an impact as eradication schemes progress and the levels of virus in cattle 
populations decrease. The existing programmes do not monitor the presence of the virus in 
other species, although their importance has been discussed and there is currently no 
evidence to suggest that other species are important in the transmission of BVDV. In Spain, 
recent studies found that although wild and domestic ruminants shared BVDV isolates 
(Rodríguez-Prieto et al., 2016), there was likely to be very little transmission between both 
(Paniagua et al., 2016). Similar results were obtained in Norway where, although BVDV PI 
animals were found in wild cervids, the infecting strains were different from those isolated 
from cattle (Lillehaug et al., 2003). In addition, in Ireland the presence of sheep on the farm 
was not associated with higher number of BVDV positive results during the voluntary stage 
of the national BVD eradication programme (Graham et al., 2013).  
 
 
1.2.4. Clinical presentations of BVD 
 
The outcomes of BVDV infection vary greatly depending on the immune status and 
pregnancy status of the animal at the time of infection. The virus is able to cause a wide 
range of clinical syndromes that are discussed in this section. 
 
1.2.4.1. Acute infections 
 
When a naïve animal is exposed to BVDV it becomes acutely infected. Acute infections are 
transient and animals undergo a short period of viraemia (3-12 days post-infection) (Müller-
Doblies et al., 2004; Pedrera et al., 2012). Depending on the virulence of the infecting strain, 
the animal may suffer from mild to moderate disease, although most acute infections remain 
subclinical (Liebler-Tenorio et al., 2003; Lanyon et al., 2014). Animals show clinical signs 
of disease between three and 15 days post-infection and the most common clinical signs 
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include high body temperature, depression, anorexia, diarrhoea and respiratory signs which 
include nasal discharge and coughing. Leucopenia with lymphopenia is also a feature of 
acute infections (Fredriksen et al., 1999; Liebler-Tenorio et al., 2003; Müller-Doblies et al., 
2004; Kelling et al., 2005). Acutely infected animals develop neutralizing antibodies 
between two and three weeks after the initial infection  and they are clinically recovered 
within three weeks (Fredriksen et al., 1999; Müller-Doblies et al., 2004). The exact duration 
of the levels of antibodies after natural exposure to BVDV is not clear. It has been shown 
that antibodies last for at least three years (Fredriksen et al., 1999), but immunity could be 
longer. Virulent strains of BVDV-1 and 2 are associated with a severe presentation of acute 
BVDV infections that, in addition to the clinical findings described previously, cause 
thrombocytopenia and mucosal ulceration (Ellis et al., 1998; Liebler-Tenorio et al., 2003; 
Hessman et al., 2012; Glotov et al., 2016). This syndrome is known as haemorrhagic 
syndrome, given the bleeding associated with the thrombocytopenia. Severe acute 
presentations of BVD could be confused with Mucosal Disease, a condition that only affects 
PI animals. Mucosal disease and the diagnoses of the different conditions caused by BVDV 
are discussed in sections 1.2.4.4 and 1.2.5 respectively. 
 
 
1.2.4.2. Reproductive consequences of transient infections 
 
Although the disease is named after its gastrointestinal signs, the effects that BVDV has on 
the reproductive function of cattle are responsible for the main losses in the herd (Houe, 
2003). In infected animals, BVDV has been recovered from most parts of the reproductive 
tract of both female and male cattle and the reproductive consequences of the disease are 
well studied (Givens and Waldrop, 2004; Grooms, 2004; Lanyon et al., 2014). However, 
part of the pathogenesis is not completely understood yet.  
 
In non-pregnant cows or heifers that are being served, BVDV infection causes infertility 
(McGowan et al., 1993; Fray, Mann et al., 2000; Fray et al., 2002). At the herd level, BVDV 
seropositivity has been associated with prolonged time-to-first calving in heifers, longer 
calving intervals in cows and increased numbers of services per conception (Niskanen et al., 
1995; Rüfenacht et al., 2001; Valle et al., 2001). In TI and PI bulls, BVDV has been isolated 
from semen, but the virus seems to not affect the concentration, motility or the percentage 
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of live spermatozoa in semen (Kirkland et al., 1991; Kommisrud et al., 1996; González 
Altamiranda et al., 2012). If a pregnant naïve animal is exposed to BVDV, the outcomes of 
the infection depend on the stage of development of the embryo or foetus (Grooms, 2004). 
After fertilisation, studies suggest that the zona pellucida may protect the embryo from the 
virus. This means that until eight gestational days, embryos are likely not to be affected by 
BVDV (Brock et al., 1997; Fray, Paton, et al., 2000). Following this stage, it has been shown 
that the virus can reach the embryo before the placenta is fully developed (at around 25-30 
days of gestation), causing early embryonic death (EED) (McGowan et al., 1993; Tsuboi et 
al., 2011). Once the placenta is functional, vertical transmission of BVDV can cause 
abortions at any stage, including late term abortions and the birth of stillborn calves 
(Blanchard et al., 2010), although immunocompetent foetuses are less likely to be affected. 
The immune system starts developing at around 120 gestational days and is not completely 
functional until 150 days. If the foetus survives abortion and is infected with BVDV before 
125 days of gestation, the virus takes advantage of the underdeveloped immunity and causes 
immunotolerance, generating animals PI with BVDV (Stokstad and Løken, 2002; Peterhans 
and Schweizer, 2013). The birth of PI calves has been reported with infections as early as 
18 days of gestation and as late as 125 days (Grooms, 2004). Since PI animals are the focus 
of one of the studies in this thesis, they are discussed in more detail in section 1.2.4.4. Once 
the foetus becomes immunocompetent, if infected with BVDV the virus will be cleared and 
the calf presents pre-colostral antibodies against BVDV at birth (Kelling and Topliff, 2013). 
These calves can be born normal; however, immunocompetent calves infected in utero have 
been reported to be more susceptible to secondary diseases (Muñoz-Zanzi et al., 2005). 
During the organogenesis of the different body systems, between 79 and 150 days BVDV 
has the ability to cause a wide variety of congenital malformations (Grooms, 2004; 
Agerholm et al., 2015). The nervous system is most commonly affected, with cerebellar 
hypoplasia being the most frequently reported malformation (Sprecher et al., 1991). Other 
neurological defects include hydrocephalus, hydrancephaly, pseudocyst formation and 
hypomyelinisation (Otter et al., 2009). The eyes can also be affected by BVDV with ocular 
and retinal degeneration, microophthalmia and congenital cataracts (Sprecher et al., 1991). 
Cranium malformations and brachygnatism have also been reported (Ross et al., 1986; 
Blanchard et al., 2010). Other types of abnormalities include thymic atrophy, renal dysplasia 
and bone and lung growth retardation (Liebler-Tenorio et al., 2004; Webb et al., 2012; 
Agerholm et al., 2015). Congenital malformations may overlap with periods of 
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immunotolerance, therefore calves born with congenital abnormalities could still be PI (Otter 
et al., 2009; Bachofen et al., 2010).  
 
 
1.2.4.3. Immunosuppression and secondary disease 
 
Bovine viral diarrhoea virus primary invades and replicates in lymphoid tissues (Pedrera et 
al., 2012; Bruschke et al., 1998). The virus has been shown to cause depletion of 
lymphocytes and to affect the normal function of macrophages (Chase, 2013), leading to 
immunosuppression and increased susceptibility to secondary diseases. Since the virus 
spreads to the whole body of infected animals, opportunist infections can be expected in 
most systems. However, respiratory disease is recognised as the most common complication 
after BVDV infection (Ridpath, 2010). The virus has been identified as an important 
component of  bovine respiratory disease (BRD) syndrome (Fulton et al., 2000; Hay et al., 
2016) and naïve animals exposed to BVD PIs have found to be twice as likely to be treated 
for respiratory problems (Grooms et al., 2014). Studies have suggested that the replication 
of the virus in lymphoid tissue in the lung is particularly high and this may explain the 
marked susceptibility to respiratory pathogens; similarly, the virus causes 
immunosuppression at the mesenteric and gut level, with particular effects in the Peyer’s 
patches, which is likely to predispose to the diarrhoea observed during acute infections (Ellis 
et al., 1998; Bolin, 2002). Other conditions associated with acute BVDV infections include 
mastitis, although no evidence has been found to suggest that the virus would affect udder 
health in the long term (Waage, 2000; Berends et al., 2008); and there are occasional reports 
of cases of autoimmune diabetes mellitus in cattle thought to have been induced by BVDV 
(Taniyama et al., 1995; Tajima et al., 1999; Clark, 2003).  
 
 
1.2.4.4. Persistent infections and mucosal disease 
 
Persistent infections are caused in utero by ncp strains of BVDV-1 or 2 (Braun et al., 2014). 
Cytopathic BVDV strains have been shown to be unable to cause PI, which is likely to be 
due to a difference in the foetal immune response against different biotypes (Chase et al., 
2004). After birth, if a PI animal’s ncp strain becomes cp by genetic rearrangement 
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(recombination, duplication, translocation or mutation) or if the animal is super-infected by 
a cp strain, the PI develops mucosal disease (MD) (Brownlie et al., 1984; Kümmerer et al., 
2000; Peterhans et al., 2010). Mucosal disease presents with ulceration of the gastrointestinal 
tract, from the oral cavity (gums, tongue, cheeks, palate) to the abomasum and small 
intestine. Interdigital and coronary band ulceration are also common findings and these can 
result in severe lameness. Affected animals are usually pyrexic, anorectic, depressed and 
suffer from severe diarrhoea that can present fresh blood or melena. Mucosal disease cases 
quickly deteriorate clinically and all animals die within weeks of the onset of clinical signs 
(Bolin, 1995). Initially, the disease was described to affect cattle under two years of age, but 
older animals have also been shown to be affected (Brownlie, 1985; Bachofen et al., 2010). 
 
Traditionally, PI cattle have been described as having retarded growth rates, to be ill thriven 
and to have increased mortality rates (Taylor et al., 1997; Stokstad and Løken, 2002; Kane 
et al., 2015). Animals PI with BVDV have been shown to have lower levels of thyroid 
hormones (Larsson et al., 1995). This, combined with the fact that BVDV can impair the 
growth of long bones (Webb et al., 2012) and lead to higher susceptibility to secondary 
diseases (Bolin, 2002; Peterhans et al., 2003), may account for the poor condition and stunted 
appearance of some PI cattle. However, many PIs have normal growth rates and live for 
years; the oldest PI identified during the Swiss eradication scheme was 11 years old (Presi 
and Heim, 2010). Regarding the reproductive function of PI cattle, studies have reported 
decreased fertility in persistently infected cows (Muñoz-Zanzi et al., 2004) and a case of 
testicular hypoplasia has been reported in a PI bull (Borel et al., 2007). However, most PI 
animals are able to reproduce and, more importantly, PI dams always give birth to PI calves 
(Lanyon et al., 2014). As discussed in section 1.2.4.2, semen from PI bulls has been shown 
to be of acceptable quality and, although the fertilization may be affected in some cases, they 
are able to transmit the disease to susceptible dams (González Altamiranda et al., 2012).  
 
 
1.2.4.5. Chronic infections 
 
In 1994, an immunocompetent, non-viraemic bull was found to be constantly shedding virus 
in semen (Voges et al., 1998).  The bull had constantly high antibody titres and the quality 
of the semen was not affected, but disease was successfully transmitted to one of three naïve 
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heifers that were inseminated with frozen semen (R. Niskanen et al., 2002). The virus was 
isolated from the animal’s semen until the day of its euthanasia. Investigation of the case led 
to the assumption that the infection was localized in the testes, protected by the blood-testes 
barrier. A second case of persistent testicular infection was confirmed years later (Newcomer 
et al., 2014). Attempts have been made to reproduce persistent testicular infections 
experimentally, but the persistence of virus in semen was shorter and these cases were 
denominated ‘prolonged testicular infections’. Prolonged BVDV infections have been 
reported in other immunoprivileged organs, including the ovarian tissue, the central nervous 
system and circulating leucocytes (Gogorza et al., 2005; Collins et al., 2009). Experimental 
transmission of BVDV was successful when susceptible animals received blood from 
animals that had persistence of BVDV in leucocytes after a transient infection (Collins et al., 
2009). Although further research is needed to fully understand the pathogenesis and 
importance of chronic BVDV infections, the existing literature suggests that they are likely 
to represent a low risk of transmission of disease (Givens and Marley, 2013). 
 
 
1.2.5. Diagnosis 
 
Bovine viral diarrhoea can be diagnosed through the detection of the BVDV antigen or 
antibodies and recent reviews of the available methods can be found in the literature 
(Sandvik, 2005; Dubovi, 2013; Lanyon et al., 2014). Virus isolation in cell cultures has 
traditionally been considered the gold standard for the diagnosis of BVDV. However, this 
technique can be affected by several factors (Dubovi, 2013) and new, very sensitive and 
specific tests like reverse transcriptase polymerase chain reaction (RT-PCR) are currently 
accepted as new reference tests (Lanyon et al., 2014).  Antigen-detection tests include the 
aforementioned RT-PCR and antigen ELISA tests (Ag-ELISA). Both methods can be used 
in a variety of samples including serum or plasma, milk and tissue.  Samples can be pooled 
and tested with RT-PCR, but not with Ag-ELISA. It has been shown that RT-PCR has higher 
sensitivity and may detect lower levels of virus, i.e. transient infections, whereas ag-ELISAs 
may miss some transient infections (Hanon et al., 2014). Immunohistochemistry (IHC) and 
immunofluorescence (IFA) are other antigen-detection techniques, with IHC being more 
reliable than IFA. However, they can only be used in tissue samples and require more 
resources (fixation of the sample in formalin, processing of the biopsy sample, etc.). 
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Antibody ELISA (Ab-ELISA) and virus serum neutralisation (SN) are the techniques 
available to test for BVDV antibodies.  
 
When dealing with the diagnosis of individual BVD cases and antigen testing, it is 
commonly accepted that two samples are needed to distinguish between transiently and 
persistently infected animals (Lanyon et al., 2014). Transiently infected animals give a 
positive antigen result if sampled during the viraemia stage. In these animals the level of 
antigen decreases as neutralising antibodies develop and two to three weeks after the initial 
infection they present neutralising antibodies, becoming antibody positive and antigen 
negative on subsequent tests (Hanon et al., 2014). By contrast, the presence of BVDV 
antigen in PI animals is constant throughout the animal’s life and it can be detected in most 
of the animal’s tissues (Liebler-Tenorio et al., 2004). The guidance for the Scottish BVD 
Eradication Scheme stipulates three weeks as the minimum testing interval to confirm a 
persistent infection (The Scottish Government, 2015b), although some references suggest to 
wait at least four weeks before re-test  (Lanyon et al., 2014). The presence of maternal 
antibodies in young calves can interfere with certain diagnostic tests for antigen by 
neutralising the BVDV antigen in PI calves to undetectable levels (Zimmer et al., 2004). 
This can be avoided by using RT-PCR or antigen capture ELISA (ACE) in skin biopsy 
samples (Larska et al., 2013; Dubovi, 2013). Recently, the case of an assumed-PI animal 
that presented decreasing levels of antigen has been reported (Fux, 2015). Cases like this 
will need further study, but this may question the belief that there is a clear distinction 
between transiently and persistently infected animals.  Animals PI with BVDV were 
traditionally assumed to be always antibody negative. However, it has been shown that PIs 
can react and become BVDV seropositive when exposed to heterologous strains of the virus 
(Fulton et al., 2003). Therefore, when suspecting persistent infection, animals should be 
tested for antigen even when an antibody positive result has been obtained.  
 
At the herd level, bulk tank milk (BTM) test can be used to monitor antibody levels and or 
the presence of antigen in milking animals. However, when used to monitor antibody levels 
in dairy farms, these need to be interpreted with caution taking into account the herd 
characteristics. Bulk tank milk tests can detect antibodies that have been circulating in the 
herd for up to three years, either as a result of natural exposure or vaccination (Houe, 1999). 
In addition, when screening a whole herd, BTM tests always need to be complemented with 
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testing of animals that are not contributing to the milk tank (i.e. youngstock, pregnant heifers 
and dry cows) (Lindberg and Alenius, 1999; Lanyon et al., 2014). 
 
Pregnant cattle that carry BVD PIs represent a challenge to the diagnosis of the disease. 
These are known as ‘trojan cows’ due to the fact that the PI animal cannot be confirmed until 
the calf is born. Some diagnostic methods have been suggested to diagnose trojan PI calves, 
although they are not commonly used. One of them is based in the fact that dams carrying 
PI calves present higher antibody titres, especially towards the end of the gestation (Lindberg 
et al., 2001). The detection of viral RNA in foetal fluids has also been used, but is a more 
complex process and requires sedation and anaesthesia (Lindberg et al., 2002). 
 
When BVDV is involved in abortions and congenital malformations, the lesions caused in 
the foetus and placenta are not pathognomonic (Grooms, 2004). It is difficult to associate 
BVDV with abortions unless seroconversion of the dam is demonstrated or the virus is 
isolated from the calf. In the case of malformations, the animal may present antibodies 
against BVDV at birth, prior to colostrum intake, but this may not be the case in all of them 
since malformations can occur before the immune system is completely functional 
(Agerholm et al., 2015). In addition, neurological deformities may also be caused by other 
viruses (e.g. Schmallenberg or Bluetongue) and non-viral causes are usually 
undistinguishable from those associated with BVDV (Agerholm et al., 2015).  
 
Diagnosis of mucosal disease (MD) cases is usually based on the confirmed BVD PI status 
of an animal, as discussed above, and the presence of gastrointestinal tract ulceration on the 
post-mortem (PM) examination. However, a definitive diagnosis of MD requires isolation 
of the cp-BVDV strain from the affected animal (Bachofen et al., 2013; Lanyon et al., 2014). 
On gross PM examination, the presentation of PI animals that have not succumbed to MD 
and animals that have been TI is very variable. Both TI and PI animals can present without 
gross significant PM lesions. However common findings include atrophy of lymphoid 
organs, including lymph nodes, Peyer’s patches, thymus, and the bone marrow, and 
gastrointestinal ulceration (Ellis et al., 1998; Liebler-Tenorio et al., 2003; Hessman et al., 
2012; Romero-Palomo et al., 2015). Lesions associated with secondary infections due to the 
immunosuppressive effects of the virus are also commonly reported in TI and PI cattle 
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(Hessman et al., 2012), pneumonic lesions being one of the most frequent findings (Taylor 
et al., 1997; Bachofen et al., 2010) 
 
 
1.2.6. The economic cost of BVD 
 
Bovine viral diarrhoea has been recognised as a disease that can have a significant economic 
impact on cattle production systems. Depending on the strain involved and the level of 
immunity of the herd, BVDV infection may result in low pregnancy rates, increased calving 
intervals, decreased growth rates, decreased milk production and increased drug costs and 
mortality due to secondary disease (Rüfenacht et al., 2001; Houe, 2003). In 2004 it was 
estimated that an endemically infected Scottish beef herd where no measures are applied to 
control BVD would lose £37 per cow per year (Gunn et al., 2004). Similar costs have been 
suggested for suckler herds in Ireland, with €32 per cow and year (Stott et al., 2012). In the 
USA, a higher value was found: exposure of feedlot cattle to PI animals was estimated to 
generate losses of $88 per animal (Hessman et al., 2009). Losses in feedlots are likely to be 
higher due to the impact that BRD has in these units (Campbell, 2004). The perception is 
that costs are higher for dairy farmers due to the negative consequences on fertility and milk 
production (Fourichon et al., 2005; Heuer et al., 2007; Stott et al., 2012). The disease was 
estimated to cost €63 per cow per year in a dairy herd in Ireland (Stott et al., 2012) and in 
France between €10 and €19 were lost per 1,000 litres of milk depending on the severity of 
the outbreak (Fourichon et al., 2005).  
 
 
1.2.7. Control of BVD 
 
When aiming to control BVD at a herd level, removing PI cattle is key to reducing the virus 
circulation in the herd. A study performed during the Irish eradication scheme found that 
herds that retained BVDV PIs were more likely to have new BVDV antigen positive animals 
the following year (Graham et al., 2015). When PIs are removed, the control of the disease 
is much easier. However, transmission of the disease has been reported in the absence of PI 
cattle (Moen et al., 2005) and the efforts to remove infected animals from the herd are likely 
to be useless if these are not accompanied by measures aimed at avoiding new exposures to 
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the virus. Biosecurity can be considered the basis of BVD control and eradication (Lindberg 
and Houe, 2005). Buying animals in has been reported as one of the most common sources 
of infection (Lindberg and Alenius, 1999; Bitsch et al., 2000; Rikula et al., 2005). Herds 
with an open status, where animals from external sources are routinely bought in, are at a 
higher risk of infection, especially when introducing cows with calves at foot and pregnant 
dams, which carry the risk of being ‘trojan cows’ (Graham et al., 2013; Gates et al., 2014). 
If cattle are bought into a herd, it is recommended that these are isolated and tested for BVDV 
antigen and antibody (Smith and Grotelueschen, 2004). Bought-in pregnant dams with 
positive antibody should be isolated and their calves tested at birth, since they could be 
‘trojan’ cows carrying PI calves. Another very common source of exposure to BVDV is 
contact with infected neighbouring stock during grazing (Smith et al., 2014). Recommended 
measures to avoid this contact include double-fencing – this is leaving a distance of at least 
one meter between neighbouring fields (Lindberg and Houe, 2005; Gates, Woolhouse, et al., 
2013), and to keep pregnant cattle and youngstock away from neighbours since these are the 
groups most susceptible to high losses. Sharing pastures between different herds, which is a 
common practice in some European regions, has also been associated with a higher 
prevalence of BVDV and should be avoided when possible (Presi et al., 2011; Graham et 
al., 2013). Contaminated environment or material used by farmers or veterinarians can also 
be a source of infection (Gethmann et al., 2015) and these should be taken into account when 
visiting various farms that may have different BVDV status. In 2004, the Finish control 
scheme included additional measures to avoid the transmission by fomites (Rikula et al., 
2005) 
 
When biosecurity measures have been applied and the virus has been eliminated from the 
herd, monitoring for BVDV is necessary to promptly detect new infections and react quickly 
(Lindberg and Houe, 2005). The different diagnostic approaches to monitor, control and 
eradicate BVD are discussed for national eradication programmes in the next section, but 
the same principles can be applied to the herd level.   
 
Cattle can be protected against BVDV infections when provided with immunity against the 
virus. Passive immunity from maternal colostrum is the first chance for animals to get 
protection against BVDV. The duration of maternal antibodies is variable, it depends on the 
level of immunoglobulins (Ig) absorbed by the calf, which partially depends on the 
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colostrum’s Ig concentration. Colostrum replacements have been shown to provide adequate 
immunity against BVDV at more constant levels, with less variability in the level of 
protection than natural, maternal colostrum (Chamorro et al., 2014). Passively derived 
antibodies may start decreasing between four and nine months of age, but in some cases they 
may persist for longer periods (Coria and McClurkin, 1978; Menanteau-Horta et al., 1985; 
Muñoz-Zanzi et al., 2002), Once maternal protection has expired, calves become 
seronegative. If exposed to the virus, naturally developed antibodies provide long term 
immunity that has been shown to last at least three years (Fredriksen et al., 1999). Controlled 
exposure of cattle to BVDV PIs prior to breeding or before entering a feedlot has been shown 
to successfully prevent the negative consequences of acute infections (Rodning et al., 2012; 
Grooms et al., 2014), but this practice is always associated with a degree of risk and is not 
recommended (Lindberg and Houe, 2005).  
 
For those animals without natural immunity to the virus, inactivated or killed and modified-
live (MLV) vaccines are available. Various articles have been published that review both 
types of vaccines (Kelling, 2004; Newcomer and Givens, 2013). Inactivated vaccines are 
generally known to be safer, since the inoculated virus cannot replicate; however, they 
induce weaker and shorter immune responses (six months) that require two initial doses and 
are effective one to three weeks after a primary vaccination schedule (Peters et al., 2004). 
Modified live vaccines, however give higher antibody responses that give earlier protection 
(five to seven days post-vaccination) (Brock et al., 2007) and last up to one year (Purtle et 
al., 2016). Risk of virulence reversion has been reported with MLV although safer vaccines 
have been developed (Newcomer and Givens, 2013). A recent study has shown that 
vaccinating animals with a MLV during late pregnancy, at drying-off, can significantly 
increase the levels of antibodies in colostrum without having negative consequences on the 
dam or foetus (Smith et al., 2015). The ability of MLV to produce an antibody response has 
been shown to be negatively affected by the presence of maternal antibodies in young calves 
(Ellis et al., 2001), although controversial results exist regarding this finding (Menanteau-
Horta et al., 1985). In addition, it has been shown that MLV can produce effective responses 
in calves that had received BVDV antibody positive colostrum when vaccinated as early as 
five weeks old (Zimmerman et al., 2006). Traditionally, most vaccines only included 
BVDV-1; however, cross-reactivity between different strains of both BVDV-1 and 2 has 
been reported (Kelling, 2004; Hamers et al., 2008).  
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Regardless of the type of vaccine used, vaccination against BVDV has been shown to reduce 
the risk of foetal infection, decrease abortion rates, improve pregnancy rates (Newcomer et 
al., 2015) and is effective in preventing acute infections (Purtle et al., 2016). Neither 
inactivated nor modified live vaccines are a hundred percent effective (Fulton et al., 2005). 
In addition, vaccination protocol compliance can also affect vaccination efficiency (Rauff et 
al., 1996; Graham et al., 2004; Moennig et al., 2005; Meadows, 2010), therefore vaccines 
should always be used in conjunction with biosecurity measures and disease surveillance to 
prevent and control BVD (Lindberg and Houe, 2005; Smith et al., 2014). 
 
 
1.2.7.1. Eradication schemes 
 
The first attempts to eradicate the disease were made in the 1990s by the Scandinavian 
countries: Norway (Valle et al., 2005), Sweden (Hult and Lindberg, 2005), Denmark (Bitsch 
et al., 2000) and Finland (Rikula et al., 2005). Since then, many European countries have 
followed their example and established new eradication programmes (Lindberg et al., 2006). 
Outside Europe, Australia and the USA are discussing options to eradicate the disease 
(Lanyon and Reichel, 2014; Givens and Newcomer, 2015). The Scandinavian approach to 
BVD eradication was based on initial serological testing of herds, followed by virological 
investigations to detect the source of virus in those herds classified as infected; the use of 
vaccines is banned (Bitsch et al., 2000; Hult and Lindberg, 2005; Rikula et al., 2005). After 
ten years of eradication, the Scandinavian countries were considered free of BVDV 
(Lindberg et al., 2006). In 2008, Switzerland launched an eradication programme with a 
different strategy (Presi and Heim, 2010). The stages of the Swiss scheme included testing 
of all cattle for BVD virus during the first year, testing of all new-born calves during the 
second year and monitoring thereafter. Vaccines were also banned and the removal of 
confirmed PI animals was compulsory. Following this approach, the prevalence of virus-
positive animals in Switzerland decreased from 1.8% to 0.2% in only two years (Presi et al., 
2011). The example of Switzerland has been followed by Germany, although vaccines are 
allowed in areas with higher prevalence, after a severe outbreak occurred in herds that had 
become naïve to the virus (Gethmann et al., 2015). Northern Ireland and the Republic of 
Ireland have based their eradication programmes on tag testing of all new-born calves, but 
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vaccination is allowed (Stott et al., 2012). Overall, all the models have found that the 
eradication of BVDV would be economically beneficial for the cattle industry (Reichel et 
al., 2008; Häsler et al., 2012; Løken and Nyberg, 2013; Stott et al., 2012), although 
differences exist between approaches (Santman-Berends et al., 2015). In answers to a survey 
carried out in the UK in 2015, the main reason cited for joining an eradication scheme was 
higher profitability (65% of farmers) and farmers that had already joined a programme 
believed that cattle were healthier (75%), that the overall productivity improved (39%) and 
that they were perceiving better prices when selling stock (33%) (Price, 2015). 
 
 
1.2.8. Bovine Viral Diarrhoea in Scotland 
 
 
1.2.8.1. Prevalence in Scotland 
 
Between 1975 and 1978, Moredun Research Institute identified BVDV, then referred to as 
‘mucosal disease virus’ (MDV), in 25% of the samples submitted for enteritis in adult cattle, 
4% of respiratory disease cases, 5% of reproductive disease and 8% of samples categorised 
as ‘others’ (Snodgrass et al, 1980). Years later, between 1996 and 2002, SRUC recognised 
a decreasing trend in the cases of mucosal disease, fetopathies and congenital diseases 
associated with BVD. Between 2002 and 2009 the percentage of abortions due to BVDV 
remained at a mean of 2.9% of the total abortion cases submitted to the SRUC (SAC 
Consulting Veterinary Services, 2010). In 2010 it was estimated that 16 % of Scottish beef 
suckler herds had active infection (presence of a PI in the herd), while 69% were not recently 
exposed to the virus. The remaining 16% could not be classified in either category 
(Brülisauer et al., 2010). In the dairy herd, in 2012, it was estimated that only 12.7% of the 
herds had low prevalence of seropositive cows in bulk milk tank tests, while 65% and 20.5% 
of the herds had moderate or high prevalence of seropositive cows, respectively (Humphry 
et al., 2012). To the author’s knowledge, no studies have been published regarding the 
specific BVDV-1 and 2 prevalence in Scottish herds. In a herd outbreak reported by SAC 
Consulting Veterinary Services in 2007 (SAC Consulting Veterinary Services, 2007), a 
BVD outbreak caused a morbidity of 30-36 % and a mortality of 19 % in a group of 36 
yearlings, with at least 4 dead animals affected with mucosal disease. 
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1.2.8.2. The Scottish BVD Eradication Scheme 
 
Following the example of the Scandinavian countries, in 1994 the Shetland Islands made the 
first attempt to eradicate BVD on Scottish land (Synge et al., 1999). The disease was 
successfully controlled in the archipelago in only three years and Shetland became free of 
BVD in 1997. In 2001, Orkney started a compulsory scheme, which had a very good 
response during the initial years. However, since 2006 almost no changes were observed in 
the BVD prevalence and re-infection was still occurring in 2008 (Truyers et al., 2010). In 
2010, with the support of the industry and the veterinary sectors (The Scottish Government, 
2010b), the Scottish Government launched a nation-wide BVD Eradication Scheme, aiming 
to continue improving the Scottish livestock health status and the standards and reputation 
of Scottish farming (The Scottish Government, 2010c). The scheme started with a stage of 
subsidised screening that ran between September 2010 and April 2011 and 4,000 herds took 
part in it (33.4% of cattle herds in 2010) (The Scottish Government, 2015a; The Scottish 
Government, 2016b). During the second stage, all breeding cattle herds had to be tested for 
BVD before 1st February 2013 and annually thereafter. Six testing methods were allowed 
during this stage, including: antibody check test in calves, testing all calves for virus, testing 
all animals for virus and, only for dairy herds, an annual bulk tank milk antibody test and 
blood testing heifers, four quarterly bulk milk tank tests and a first lactation composite milk 
test (The Scottish Government, 2014). Herds are given a ‘negative’ or ‘not negative’ status 
based on the annual screen result. In 2013 the eradication scheme database became operative 
on ScotEID (ScotEID, 2016). Since then, all members of the public can access the database 
to look up and check an individual animal’s test results and/or herd’s status based on the ear 
tag or County Parish Holding (CPH) number respectively. In January 2014, with the start of 
the third stage, the first control measures came into effect: animals identified as persistently 
infected with BVD could no longer be moved or sold, all herds had to declare their status 
before selling animals and restrictions were applied to those herds that failed to meet the 
mandatory testing requirements. Finally, in June 2015 Scotland entered the fourth stage of 
the scheme and new legal restrictions were applied. Currently, PI animals can only be moved 
directly to slaughter and animals from ‘not negative’ herds cannot be moved to other farms 
unless individually tested for virus (and with a negative result), and any animals entering a 
herd from an untested source must be tested for virus (The Scottish Government, 2015b). In 
addition to the ‘not tested’, ‘negative’ or ‘positive’ BVDV status for individual animals, a 
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new status has been added for dams that have had a calf that tested negative on antigen tests. 
These are ‘assumed negative’ cows and can be moved from not negative herds without being 
individually tested. The testing options have been reduced to only four: the calf antibody 
checks have been maintained for block calving beef or dairy herds, as well as the options of 
testing all calves or animals for virus and a new option has been introduced, which consists 
of testing calves for antibody every six months for dairy herds that calve all year round (The 
Scottish Government, 2015b).  
 
Before the start of the Scheme it was calculated that 40% of Scottish herds were exposed to 
BVDV (not-negative). By the end of 2015 the prevalence had been reduced to 12.5% (The 
Scottish Government, 2016d). Initially, only 23% of beef herds were exposed to BVD, as 
opposed to 52% of dairy herds (The Scottish Government, 2012). It was expected that 
removing the BTM tests would help accelerate the eradication process in dairy herds, since 
BTM tests can detect antibodies in milk due to historic infection or vaccination and may not 
accurately reflect what is going on in the herd at the time of testing (Lindberg and Alenius, 
1999). Furthermore, evidence shows that farmers re-test animals quicker if a positive antigen 
result is obtained from a blood rather than a milk sample (Duncan et al., 2016). By August 
2016 over 4,700 animals in total had been confirmed as PI and the number of PI cattle 
identified per year increased from 759 and 742 in 2013 and 2014 respectively, to 1,479 in 
2015 (J. Purcell, personal communication, August 2016), which clearly suggests that the 
removal of the BTM tests has been beneficial to the eradication process. However, 472 of 
these PI cattle were still alive in August 2016 and as a consequence new infections are still 
likely to occur (Graham et al., 2015). To the author’s knowledge, no studies have been 
published yet to support the progress made by the Scottish BVD Eradication Scheme. Using 
data from the 2006-15 BVD PI SCPAHFS caseload, Chapter 5 presents the analysis of 
clinical records of PI cattle and assesses any changes in their clinical presentation that may 
have happened as a consequence of the launch of the Scheme.  
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2. Materials and Methods 
 
 
2.1. Background: The Scottish Centre for Production Animal 
Health and Food Safety 
 
The University of Glasgow’s School of Veterinary Medicine celebrated its 150th anniversary 
in 2012. The school was initially based at Buccleugh Street in the city centre but it later 
moved to Gilmorehill, where it stayed until the 1950s before moving again to its current 
location at the Garscube Estate (Yam et al., 2012). Historically, the farm animal buildings 
were known as ‘the Byres’, three blocks of animal buildings that were completely 
remodelled in 2010. Since the establishment at Garscube, the farm animal department has 
worked closely with the pathology group. The post-mortem facilities are located next to the 
Byres. Farm animal cases are donated to be used for teaching and receive full diagnostic 
work-up and necessary treatments. When an animal is euthanased, a full gross post-mortem 
(PM) examination is performed by the Anatomical Pathology Department.  
 
In 2011, after remodelling of the Byres, the Scottish Centre for Production Animal Health 
and Food Safety (SCPAHFS) was created. The SCPAHFS comprises a team of farm animal 
and public health lecturers and clinicians. The main aim of the SCPAHFS department is to 
teach under- and post-graduate veterinary students as well as providing services to external 
farms, including the University owned Cochno Farm, advise veterinary surgeons and take 
part in farm investigations. Central to the SCPAHFS department is the Galloway Building. 
The Galloway Building is a farm animal clinic that receives farm animal cases donated from 
farmers via a referring veterinary surgeon. These cases are used for teaching veterinary 
students and receive a diagnostic work up as detailed below. The Galloway Building case 
load generates a large amount of animal health data that are currently not used for 
surveillance purposes. 
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2.1.1. Admission of cases and daily routine at the Galloway Building 
 
The SCPAHFS receives animals referred by first opinion practitioners and farmers across 
Scotland and northern England. Although typically uneconomic cases or cases in which a 
diagnosis could not be reached, individual animals can be sent as part of a herd or flock 
investigation. All animals are used for teaching purposes. Although the final (fifth) year 
Bachelor in Veterinary Medicine and Surgery (BVMS) students have the greatest 
involvement with these cases, those in second, third and fourth year also utilise them in 
developing clinical examination and clinical reasoning skills. Farm animal Junior and Senior 
Clinical Scholars (interns and residents, respectively) and post-graduate students also get 
involved with the cases. Additionally, the SCPAHFS receives students undertaking work 
experience, visitors from veterinary schools across Europe, farmers’ meetings organised 
through the National Farmers Union (NFU) Scotland and helps with the delivery of Official 
Veterinarian (OV) training courses, all of whom are exposed to the case load of the Galloway 
Building.   
 
The process of admitting an animal to the Galloway Building starts with a first opinion 
veterinary practitioner contacting the SCPAHFS. The referring veterinarian and a clinician 
from the SCPAHFS discuss the case and  the clinician completes a history form (see 
Appendix 1). The referring veterinarians are always asked to confirm that the animal is fit 
for transport (Anon, 2005). Once the case is confirmed fit for transport, the SCPAHFS 
clinician will phone the farmer and take a history from the farmer (see Appendix 1). The 
clinician will arrange the transport of the animal, which is carried out by one of the 
University’s stockpersons free of charge. All cases are admitted as donations to the 
University of Glasgow, and a payment of £40 and £20 as a gesture of gratitude is offered for 
each cattle and sheep case respectively. If a farmer refers two animals with the same clinical 
presentation, only one payment is made. At the time of collection, the farmer or owner signs 
a consent form certifying the donation of the case to the University of Glasgow for teaching 
and research purposes (Annex 1). 
 
Until 2012 the farm animal rotation in the fifth year of BVMS ran from September/October 
to May, with a four-week break during Christmas. With a reorganisation of the teaching in 
2013, the rotation now runs for ten blocks of four weeks, with a four-week break in 
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July/August and four more weeks in December/January. During the final year farm animal 
core rotation, each final year student spends two weeks in the Galloway Building.  
 
When a new animal arrives the clinician on duty performs a general assessment of the 
animal. If the animal is distressed or tired after the transport, especially after longer journeys, 
it will be left to rest in the pen before proceeding with a full clinical examination (unless 
emergency treatment is required). Each case is assigned to a pair of students who perform 
the first full clinical examination of the animal, supervised by a clinician. Animals are 
weighed and blood samples are taken for diagnostic purposes. The students perform an in-
house packed cell volume (PCV, haematocrit) and a total protein (TP). Heparin- and EDTA-
anticoagulated blood samples are routinely sent for a basic biochemistry profile and full 
haematology. Students are required to manage cases on a daily basis, this includes clinical 
examinations, diagnostic interventions and treatments. The animals’ diagnoses, progression 
and plan are discussed at daily rounds with the clinician and resident or intern on duty in the 
Galloway Building. In addition to the routine bloods taken after the animal's admission, 
ancillary tests are performed as needed. These include tests such as parasitology, serology, 
cytology, urinalysis, ultrasound (US) scans and biopsies. Radiographs, post-mortem 
Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans may be 
performed in specific cases. The decision when to euthanase an animal is always based on 
the welfare of the animal and prognosis of the clinical diagnosis. Occasionally animals do 
respond to treatment and cases are either sold direct to an abattoir or remain in the Galloway 
Building as static teaching cases. Following euthanasia of any animal in the Galloway 
Building, the Anatomical Pathology Department performs full gross PM examination on 
these cases and a PM report is produced. Samples for histopathology are taken in cases of 
special interest or when the owner is willing to pay for further testing. The PM examinations 
provide important information to the case picture and very often will provide or confirm a 
final diagnosis. After each post-mortem examination findings are communicated via a phone 
call to both the referring veterinarian and the farmer. When the final PM report is received, 
the intern or resident that admitted the case will write and send a letter to the referring 
veterinary surgeon summarising the progression and findings in that particular animal. In 
those cases where diagnostic work up detects issues that could have herd or flock 
implications, contact with the referring veterinarian and farmer is made as soon as possible.  
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2.1.2. Data storage and recording 
 
Each case admitted to the SCPAHFS is identified with a case number, which is generated 
by a practice management system (AT Veterinary Systems, 2016), where the animal’s ear 
tag, species, breed, sex and date of birth are recorded. The owner details (farmer’s name, 
farm address, postcode and contact numbers), referring practitioner and veterinary practice 
are also recorded in the same database. Case labels are printed using the AT System and 
these will be used to identify the animal’s case file, samples and laboratory submission 
forms. The case file is a paper folder that contains all its information, such as the case labels 
(see Appendix 3), the farmer and veterinary surgeon history forms (See Appendix 1), a copy 
of the animal’s passport (if applicable), the clinical examination sheet completed by the 
students during the animal’s first full exam (Appendix 4), the daily progression or TPR 
(temperature, pulse, respiration) sheets (Appendix 5), an additional diagnostic results sheet 
(Appendix 6) and a communication sheet where any conversations with the farmer or 
veterinarian are recorded (Appendix 7). Diagnostic reports (biochemistry, haematology 
results and additional tests) (Appendices 8 and 9) will be added to the case file as they are 
received. When an animal is euthanased, the case file is transferred to an envelope that is 
also identified with a case label. These ‘dead’ case files are stored in numerical order (based 
on the case number) and have been kept in the SCPAHFS offices since the 1960s.  
 
In addition to the paper case file, an electronic case folder is created for each case under the 
Department’s secure network drive. The electronic copies of laboratory and post-mortem 
reports, as well as the letter to the referring veterinarian and any images are saved in this 
folder. Since 2004, summaries of every animal admitted to the SCPAHFS have also been 
recorded in Microsoft (MS) Office Excel (see Table 2.1).  In January 2015, four new columns 
were added to the spreadsheet: species, sex, farm postcode and clinical diagnosis (reached 
at the SCPAHFS).  
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‘SCPAHFS cases’ spreadsheets 
 Date of admission 
 Initials of the intern/resident on clinics 
 Initials of the clinician on clinics 
 Ear tag 
 Age 
 Species 
 Breed 
 Sex 
 Owner’s name 
 Farm postcode 
 Referring veterinarian’s name 
 Veterinary practice 
 Referring diagnosis 
 Clinical diagnosis 
 Post-mortem date 
 Post-mortem diagnosis 
Table 2.1  MS Office spreadsheet structure. The fields 
added in 2015 appear in italics. 
 
 
2.2. Ethics approval 
 
For the three retrospective studies and the case study presented in chapters three to six, 
ethical approval was granted by the Ethics & Welfare Committee of the School of Veterinary 
Medicine of the University of Glasgow.  
 
 
2.3. Data collection and cleaning 
 
 
2.3.1. Analysis of SCPAHFS caseload (2006 – 2015) 
  
Data for this study were obtained from the 2004-15 MS Office Excel spreadsheets. Only 11 
cases were recorded in 2004-05 therefore these years were excluded. A new spreadsheet 
named ‘Cases 2006-15’ was created with a copy of all the cases recorded in the original file 
between January 2006 and December 2015. The following fields were added to the new file: 
species (cattle, sheep, pigs, goats, and alpacas), type (dairy or beef, only for cattle cases), 
years old, farm postcode and affected system. The post-mortem date and diagnosis fields 
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were missing for more than 50% of the cases and were therefore excluded. Table 2.2 shows 
all the fields included in the ‘Cases 2006-15’ spreadsheet. The original ‘referring diagnosis’ 
field included both clinical signs and diagnoses and the column’s title was changed to 
‘referral reasons’.  
 
‘Cases 2006-15’ spreadsheet 
 Case number 
 Date in 
 Species 
 Breed 
 Type (dairy or beef, only for cattle) 
 Age 
 Years old 
 Owner 
 Farm postcode 
 Practice 
 Referral reason - Affected system 
 Referral reason 
Table 2.2 Categories included in the spreadsheet 
used for the 2006-15 caseload analysis. The 
fields in italics were added to the new 
spreadsheet. 
 
The breeds, owners’ and practices’ names were checked for misspellings and where 
information was missing, the AT System was consulted to confirm the missing information. 
The correct names of the veterinary practices were also checked on the internet, using the 
practice’s website and/or the Royal College of Veterinary Surgeons (RCVS) directory 
(Royal College of Veterinary Surgeons, 2016). If the farm’s postcode was missing on the 
AT System, this was obtained by searching the farm’s address online (Google, 2016; 
Streetmap EU Ltd, 2016). Postcodes that could not be identified were marked as ‘missing’. 
At the same time, the practices’ location (latitude and longitude) was obtained from Google 
Maps with the aim to calculate the distance by road to the SCPAHFS (Google, 2016). The 
referral reasons were also checked for misspellings and similar expressions were grouped 
under one term, e.g. ‘chronic pneumonia’ and ‘pneumonia’ were grouped under 
‘pneumonia’, ‘ill thrift’, ‘stunting’ and ‘weight loss’ were grouped under ‘alterations of body 
weight and/or size’. Finally, referral reasons were assigned to an ‘affected system’. Although 
the VIDA report is based on diagnoses and not clinical signs and comparison with the 
SCPAHFS’ referral reasons was not possible, the ‘affected system’ categories were 
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established using the VIDA report groups (Animal and Plant Health Agency, 2015c). In 
addition to the different body systems and ‘diagnosis not reached’ and animals with ‘no 
clinical problem’ that are already included in VIDA, the classification in this study also 
included a category for ‘diagnosis not recorded’ for those cases were a referral reason was 
missing on the Excel spreadsheet. The categories are summarised in table Table 2.3. 
 
Affected system 
 Systematic disease and those not readily classified organically 
 Digestive system 
 Respiratory system 
 Urinary system 
 Musculo-skeletal system 
 Nervous system and organs of special sense 
 Skin 
 Blood and lymph circulatory and poietic systems 
 Reproductive and mammary system 
 No clinical problem 
 Diagnosis not reached 
 Diagnosis not recorded 
Table 2.3 Categories of affected systems.  
 
With the aim to compare the SCPAHFS caseload with the Scottish livestock population and 
the submissions to the VIDA database, the total numbers of cattle, sheep, pigs, goats and 
alpacas in Scottish holdings in June 2006-15 were obtained from the 2006-15 Economic 
Report on Scottish Agriculture (The Scottish Government, 2016b) and the total number of 
samples per species submitted to VIDA were retrieved from the 2013 and 2014 reports 
(Animal and Plant Health Agency, 2014c; Animal and Plant Health Agency, 2015c). With 
the aim to compare the age distribution within the SCPAHFS caseload, cattle and sheep 
cases were grouped into categories following the classification used in the Economic Report 
on Scottish Agriculture (The Scottish Government, 2016b). Cattle were grouped into three 
categories: ‘under one year old, ‘between one and two years old’ and ‘two years old and 
over’. Sheep were divided into two groups: ‘under one year old’ and ‘one year old and over’. 
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2.3.2. Diagnoses reached at the SCPAHFS in 2015 and comparison to the 
VIDA report 
 
Based on the ‘Cases 2006-15’ file, a second spreadsheet was created with a copy of all the 
cases admitted in 2015. This was named ‘Cases 2015’ and four new columns were added to 
this file: ‘clinical diagnosis’, ‘post-mortem diagnosis’, ‘final diagnoses and ‘final diagnosis 
– affected system’ (see Table 2.4). Clinical and post-mortem diagnoses were established 
using laboratory and post-mortem reports and the case letters sent to the referring 
practitioners. In the cases where information was missing, the paper copy of the case file 
(which includes the clinical examination and TPR sheets) was consulted. The final diagnosis 
was deduced from both the clinical and post-mortem diagnoses and up to three terms were 
recorded for each animal, for example, in bovine viral diarrhoea virus (BVDV) persistently 
infected (PI) cases where there were no post-mortem findings, the final diagnosis was 
‘BVDV PI’, but if the same animal had bronchopneumonia and chronic fascioliosis on post-
mortem, all three diagnoses were recorded. Finally, all the final diagnoses were assigned to 
an affected system category following the same classification described in section 2.3.1.  
 
‘Cases 2015’ spreadsheet 
 Case number 
 Date in 
 Species 
 Breed 
 Type  
 Age 
 Years old 
 Owner 
 Farm postcode 
 Practice 
 Referral reason - Affected system 
 Referral reason 
 Clinical diagnosis 
 Post-mortem diagnosis 
 Final diagnosis - Affected system 
 Final diagnosis 
Table 2.4 Fields included in the ‘Cases 2015’ 
spreadsheet. The fields in italics were added to this 
new spreadsheet. 
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The age distribution of cattle and sheep in Scottish holdings was obtained from the 2015 
Economic Report on Scottish Agriculture (The Scottish Government, 2016b) for comparison 
with the SCPAHFS 2015 cattle and sheep caseload age distribution.  
 
With the aim to compare the final diagnoses reached at the SCPAHFS with the diagnoses 
reported in the VIDA, the latter were obtained from the 2014 report (Animal and Plant Health 
Agency, 2015c) which was the last report available at the time of analysing the data for this 
study. 
 
 
2.3.3. Progression of the clinical presentation of BVDV PI cattle at the 
SCPAHFS in relation to the launch of the Scottish BVD Eradication 
Scheme  
 
For the third study, the original MS Excel spreadsheet was searched for cases that had the 
terms BVD, BVD PI or mucosal disease as referral reason or post-mortem diagnosis. In 
addition, cases referred for pneumonia, ill thrift, diarrhoea and cerebellar hypoplasia were 
also identified. The paper copies of these files were searched and any cases with positive 
BVDV antigen results were retrieved and included in the data set. All the information 
included in the selected animals’ case files was transferred to a relational database created 
with MS Office Access database (design is described in section 2.2.3.1).  Only those animals 
that had evidence of having been tested twice for BVDV antigen, at least three weeks apart 
or that were tested once and had a final diagnosis of mucosal disease, were included in the 
final analysis. For cases admitted after 2013, if BVD results were missing from the history 
or case file, the Livestock Traceability EID Research BVD Lookup (ScotEID, 2016) was 
consulted to confirm BVD antigen results. Specific information from the BVD database was 
then transferred to separate MS Office Excel spreadsheets. The fields included in the 
spreadsheets are summarised in Table 2.5. Based on the date of admission, each case was 
assigned to a stage, ‘pre’ or ‘post’, in accordance with the  implementation of the Scottish 
BVD Eradication Scheme, ‘pre’ (January 2006 - August 2010) or ‘post’ (September 2010 - 
December 2015).  
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From the clinical examination of the animals at the SCPAHFS, animals were classified as 
presenting alterations or not in seven different categories: cardiovascular signs, respiratory 
signs, diarrhoea without mucosal disease, mucosal disease, musculoskeletal abnormalities, 
neurological signs and ocular signs. Animals were considered to have respiratory disease 
when they presented with two or more of these signs: increased body temperature, harsh 
lung sounds, upper respiratory tract noises, nasal discharge and coughing. The diagnosis of 
mucosal disease was based on the presence of depression, ulceration and diarrhoea.  
 
Signalment 
 Case ID 
 Case number 
 Date admitted 
 Stage  
 Ear tag 
 Breed 
 Type (beef or dairy) 
 Sex 
 Date of birth 
 Years old 
Farms 
 Case ID 
 Date admitted 
 Stage 
 Farm postcode 
 Postal area 
Practices 
 Case ID 
 Date admitted 
 Stage 
 Practice name 
 Postcode 
 Postal area 
History 
 Case ID 
 Date admitted 
 Stage  
 Farmer mentioned BVD 
(yes / no) 
 Vet mentioned BVD 
(yes / no) 
 Farmer has other 
complaints (yes / no) 
 Farmer complaints (up 
to three) 
 Vet has other 
complaints (yes / no) 
 Vet complaints (up to 
three) 
Clinical presentation 
 Case ID 
 Date admitted 
 Stage 
 Cardiovascular 
 Respiratory  
 Mucosal Disease (MD) 
 Diarrhoea (without MD) 
 Musculoskeletal 
 Neurological signs 
 Ocular disease 
PM diagnoses 
 Case ID 
 Date admitted 
 Stage 
 PM diagnoses 
Table 2.5 Summary of fields included in the spreadsheets used for the BVD Cases study. 
 
 
2.3.3.1. Database creation 
 
To facilitate the data recording and analysis for the BVD PI study a relational database was 
created using MS Office Access. The tables included in the database and their relationships 
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are summarised in Figure 2.1. The forms included in the database followed the structrure of 
the forms included in the paper case files (see Appendices 1 and 4 to 9). This database was 
also created with the aim to be potentially used as a future recording system for all the cases 
admitted to the SCPAHFS. 
 
 
Figure 2.1 Structure of the relational database used for study presented in Chapter 5. Data in boxes with text 
in italics were not included in the study. 
 
 
2.3.4. BVD Case Study 
 
During the data collection for the BVD PI study, five PIs were identified that were referred 
from the same farm in a period of just over a year. With the aim to study this outbreak and 
with approval from the Ethics Committee, a meeting was arranged with the farmer. An 
interview draft was prepared before the meeting to facilitate the discussion. The two farmers, 
their first opinion veterinary surgeon and three researchers were present during the interview. 
Any information that needed to be clarified was discussed at a later date via telephone call. 
The farmer and first opinion veterinarian were given the opportunity to review the final case 
study. 
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2.4. Data analysis 
 
 
2.4.1. Analysis of the SCPAHFS caseload (2006-15) 
 
The data in this thesis were mainly analysed and presented using MS Office Excel. The total 
number of cases admitted to the SCPAHFS per species were compared to the mean number 
of cattle, sheep, pigs, goats and alpacas in Scottish holdings in June 2006-15 using a Chi-
square “goodness of fit” test (Lowry, 2016). The caseload was also compared to the total 
number of samples submitted to the VIDA system in between 2006 and 2014 using the same 
test. The number of total monthly cases were divided in two periods: 2006-2011 and 2012-
16 with the aim to evaluate the effect that the reorganisation of final BVMS teaching had in 
the number and type of admissions during the year. The age distribution of dairy and beef 
cattle admitted to the SCPAHFS was compared using a Chi-square test for association using 
Minitab (Minitab Inc., 2016). 
  
The postal areas of the referring farms rather than full postcode were used to analyse the 
origin of the cases in order to protect the farms’ privacy. The postal areas were located on a 
map created with QGIS, an open source geographic information system (QGIS, 2016). 
Geospatial data for the map layout (postal areas) were obtained from ShareGeo Open 
(DSpace, 2016). The referring practices, Scotland’s Rural College (SRUC) Disease 
Surveillance Centres (DSC) and SCPAHFS were located on the map using their 
geographical coordinates, obtained by looking up their addresses on Google Maps (Google, 
2016). Four separate maps were created for the total number of cases, the number of dairy, 
beef and sheep cases admitted to the SCPAHFS. With the aim to be able to compare the 
volume of cases for the different species and between chapters 3 and 4, the same thematic 
shading was used in the colour scale of all the maps. The distance by road between the 
referring veterinary practices and the SCPAHFS was calculated using Google Maps.  
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2.4.2. Diagnoses reached at the SCPAHFS in 2015 and comparison to the 
VIDA report 
 
The data analysis in Chapter 4 was very similar to that described in the previous section. The 
total number of cases admitted to the SCPAHFS per species in 2015 were compared to the 
total number of submissions per species made to the VIDA database in 2014 using a Chi-
square “goodness of fit” test using an online statistical table calculator (Lowry, 2016). The 
same test was used to compare the age distribution of cattle and sheep admitted to the 
SCPAHFS in 2015 with the age distribution of cattle and sheep in Scottish holdings in June 
2015 (The Scottish Government, 2016b). In this study only one map was created, showing 
the location of the total cases admitted in 2015 and their referring veterinary practices. The 
proportion of referral reasons for cattle and sheep admitted to the SCPAHFS presented in 
bar graphs with error bars denoting binomial 95% confidence intervals. The same method 
was used to present and compare the SCPAHFS 2015 and VIDA 2014 diagnoses grouped 
by affected system. The individual SCPAHFS diagnoses were compared to the equivalent 
VIDA categories in a separate graph. 
 
 
2.4.3. Progression of the clinical presentation of BVDV PI cattle at the 
SCPAHFS in relation to the launch of the Scottish BVD Eradication 
Scheme  
 
The BVD PI case information recorded on the MS Office Access database was exported and 
analysed using Excel. Chi-square tests of association were used to compare the proportions 
of beef and dairy, male and female and age distribution of the cases admitted before and 
after the Scottish Government BVD eradication scheme. Maps for the total number of BVD 
PIs and for the number of PIs admitted before and after the start of the scheme were created 
using QGIS (QGIS, 2016). Given the small number of cases referred per postal area in this 
study, only one colour was used to indicate the areas with cases. The respective referring 
practices and SRUC DSC were also located on the maps.  
 
From the history of the BVD PI cases, the number of cases where the farmer and first opinion 
veterinarian mentioned BVD before and after the start of the scheme were compared; 
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however, Chi-square tests of association were not performed since the numbers of some 
observations were fewer than five. The number of cases where the farmer and veterinarian 
reported clinical signs were compared using Chi-square tests of association and, in those 
cases in which signs were reported, these were compared between cases admitted before and 
after the start of the scheme in a clustered column graph with error bars denoting binomial 
95% confidence intervals. The same methods were applied to the number of cases that 
presented clinical signs on the clinical examination on admission at the SCPAHFS before 
and after the start of the scheme and the presence of significant findings on the post-mortem 
examination.   
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3. Analysis of the SCPAHFS caseload (2006-15) 
 
 
3.1. Introduction 
 
The final report of the review of veterinary surveillance, known as ‘the Kinnaird report’, was 
published in 2011 by the Scottish Government. The document identified the need for more 
efficient, cost-saving approaches and recommended that surveillance should include data 
from additional existing animal health sources (The Scottish Government, 2011).  The cases 
admitted to Scottish Centre for Production Animal Health and Food Safety (SCPAHFS) 
generate a large amount of animal health data that are used for teaching and research 
purposes; however, their potential as a source of surveillance intelligence has never been 
evaluated. In addition, although cases have been used in studies that focused on particular 
diseases (Clements et al., 2002; Bexiga et al., 2007; Bexiga et al., 2008), the demographics 
and characteristics of the SCPAHFS caseload as a whole have never been analysed. One of 
the aims of this thesis is to evaluate the usefulness of the SCPAHFS as an additional source 
of passive surveillance data. The study presented in this chapter is based on the analysis of 
the case details recorded on spreadsheets between 2006 and 2015 and aims to present the 
characteristics and demographics of the SCPAHFS caseload to perform a first evaluation of 
its potential usefulness as a source of surveillance intelligence. At the same time, the results 
of this analysis can be used as a background for future studies based on the SCPAHFS 
caseload.  
 
 
3.2. Results 
 
 
3.2.1. Number of cases 
 
A total of 1,727 cases were admitted to the SCPAHFS between 1st January 2006 and 31st 
December 2015; a mean number of 173 animals per year. Figure 3.1 shows the total number 
of cases. Cattle represented the majority of the caseload (64%) and were divided in 53% 
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dairy (594 animals, 34% of total cases) and 47% beef (510 animals, 30% of total cases). No 
poultry admissions were recorded on the Excel spreadsheets. The species distribution of the 
SCPAHFS caseload was significantly different (p < 0.05) from the mean distribution of 
cattle, sheep, pigs, goats and alpacas in Scottish holdings during 2006-15 (June census) – 
where sheep represent 76% of the population (Figure 3.2); and it also differed from the total 
number of samples submitted per species to the VIDA database from 2006 to 2014 (Figure 
3.3), with more sheep being admitted to the SCPAHFS (p < 0.005). 
 
 
Figure 3.1 Number of cases admitted to the 
SCPAHFS between 2006 and 2015 (percentage of 
total caseload shown below the actual number). 
1Includes pigs, goats and alpacas. 
 
Figure 3.2 Mean number of livestock in Scottish 
holdings in between June 2006 and 2015 (The 
Scottish Government, 2016b). 1Includes pigs, goats 
and alpacas. 
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Figure 3.3 Number of samples submitted to the VIDA 
system between 2006 and 2014 (Animal and Plant Health 
Agency, 2014c; Animal and Plant Health Agency, 2015c). 
2Includes pigs and goats. 
 
Figure 3.5 represents the number of cases admitted to the SCPAHFS per species and year. 
The year with fewest cases was 2012, with 113 animals admitted and, since 2013, there has 
been an increase in the number of annual admissions, with 227 and 228 animals being 
admitted in 2014 and 2015 respectively.  
 
 
Figure 3.4 Total number of cases admitted to the SCPAHFS per year and species. 
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The monthly trends for the total number of cases admitted each year are shown in Figures 
3.5 and 3.6. During 2006-11 there was a marked decrease in the number of cases in summer, 
with most years having no cases at all in July. This was followed by a peak of cases in 
October. From 2012 to 15 the admissions were more constant during the year, with cases 
being admitted in every month. 
 
 
Figure 3.5 Number of cases admitted to the SCPAHFS per month between 2006 and 2011. 
 
 
Figure 3.6 Number of cases admitted to the SCPAHFS per month between 2012 and 2016. 
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3.2.2. Age distribution 
 
The age distribution of the animals admitted to the SCPAHFS in 2006-15 are represented in 
Figures 3.7 and 3.8 total cattle and sheep and Figures 3.9 and 3.10 for dairy and beef cattle, 
respectively. There was a significant difference (Chi-square test, p = 0.000) between the age 
distributions of dairy and beef cattle, as the distribution of dairy cases was significantly older 
than beef cases. In both graphs there was a total of 2-3% of animals without an age recorded 
in the Excel spreadsheet. In the case of sheep, 19% of the animals did not have a recorded 
age and the majority of the caseload was over a year old (62%). 
 
 
Figure 3.7 Age distribution of cattle admitted to the 
SCPAHFS (2006-15). 
 
Figure 3.8 Age distribution of sheep admitted to the 
SCPAHFS (2006-15). 
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Figure 3.9 Age distribution of dairy cattle admitted to 
the SCPAHFS (2006-15).  
 
Figure 3.10 Age distribution of beef cattle admitted to 
the SCPAHFS (2006-15). 
 
 
3.2.3. Origin of the cases 
 
A total of 77 different veterinary practices and 591 farms referred cases to the SCPAHFS 
between 2006 and 2015. Figure 3.11 shows the number of farms and practices that referred 
cases each year. While the number of referring practices remained more or less stable during 
the ten years included in this study (between 20 and 30 practices a year), there has been a 
progressive increase in the number of referring farms since 2006, with only two decreases 
in 2007 and 2011-12. The farms were located in 16 postal areas of Scotland (13 areas), 
Northern England (two areas) and Northern Ireland (one area). Figures 3.13 to 16 show the 
number of total, dairy cattle, beef cattle and sheep cases admitted per postal area (Northern 
Ireland case not shown) and the location of the respective referring practices. The eight 
Scotland’s Rural College Disease Surveillance Centres (DSC) are also shown on the map. A 
total of 219 cases did not have a referring practice recorded. The postcodes of eight farms, 
corresponding to nine cases and the location of ten veterinary practices could not be 
identified. The majority of cases originated from Central and South-West Scotland, being 
the postal areas closest to the SCPAHFS, G, ML, PA and KA, the ones that presented the 
highest number of cases with over 250 animals referred per area during the ten-year period. 
The higher concentration of cases coincided with the presence of more referring practices in 
the same postal area. When looking at the individual maps for dairy cattle, beef cattle and 
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sheep, the concentration of cases around the SCPAHFS is clearer, especially in the case of 
sheep. Over 100 sheep were received from G, ML, PA and KA, and less than 20 cases were 
referred from each of the remaining postal areas. In relation to the DSC, the SCPAHFS 
caseload overlapped with the areas covered by the Ayr and Dumfries centres, with 254 and 
172 cases received from KA and Dumfries (DG), respectively. 
 
Regarding the number of cases referred per practice in relation to the distance to the 
SCPAHFS (Figure 3.12), although all the practices that referred more than 50 cases during 
2006-15 were located under 100 km from the SCPAHFS, there was not a clear relationship 
between distance and number of cases. Many practices under 50 km from Glasgow referred 
less than 25 cases during the ten-year period, whereas a practice located over 150 km from 
Glasgow referred 46 cases. The mean number of cases referred per practice was 27. 
 
 
Figure 3.11 Number of referring veterinary practices and farms per year. 
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Figure 3.12 Number of cases referred per practice between 2006 and 2015 in relation to the 
distance by road to the SCPAHFS. The black square represents the SCPAHFS (0 km 
distance), whose own clinicians referred 250 animals.  
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Figure 3.13 Total number of cases referred per postal area (2006-15) and location of the referring veterinary 
practices and SRUC DSC. 
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Figure 3.14 Dairy cattle referred per postal area (2006-15) and location of their referring veterinary practices 
and SRUC DSC. 
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Figure 3.15 Beef cattle referred per postal area (2006-15) and location of their referring veterinary practices 
and SRUC DSC. 
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Figure 3.16 Sheep referred per postal area (2006-15) and location of their referring veterinary practices and 
SRUC DSC. 
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3.2.4. Referral reasons 
 
The proportions of referral reasons grouped by affected systems for both cattle and sheep 
are summarised in Figure 3.15. Overall, the distribution of affected systems was similar 
between both species, with some differences. In the case of cattle, diseases of the digestive 
system were the most common reason for referral, with 35% of the referred animals being 
affected (391 animals). Systemic diseases were in second place, being the referral reason of 
20% of the cases (225 animals), and respiratory diseases were third presenting in 13% of the 
cases (142 animals). These were followed by diseases of the circulatory and poietic system 
(12%, 130 animals) and musculoskeletal diseases (11%, 122 animals). Neurological (6%, 65 
animals), reproductive (5%, 55 animals), urinary (3%, 33 animals) and skin diseases (2%, 
17 animals) individually represented less than 10% of the cattle referral reasons. Only 1% 
of the cattle were referred without a diagnosis (11 animals) and 4% were admitted without 
clinical problems (49 animals). In the spreadsheet, 3% of cattle were missing a referral 
reason (30 animals). 
 
Digestive disease was also the first referral reason of the SCPAHFS sheep caseload with 
24% of the cases (128 animals). Respiratory disease was the second most common condition 
with 20% of affected animals (107 animals), followed by systemic disease (17%, 90 animals) 
and musculoskeletal problems (11%, 57 animals). Reproductive (9%, 49 animals) and 
neurological (8%, 48 animals) disease were less important, and only 11 sheep were presented 
with skin (1%, 6 animals) and circulatory (1%, 5 animals) problems. No sheep were admitted 
for urinary disease. Healthy animals represented a larger proportion of the sheep caseload 
than they did in cattle, with 12% of sheep being admitted without a clinical problem (65 
animals); and 1% did not have a final diagnosis (7 animals). The proportion of cases that 
were missing a referral reason in the Excel spreadsheet was also larger than cattle with 5% 
of the cases without a recorded reason (26 animals).  
 
When looking into the individual referral reasons (Table 3.1), alterations of body weight 
and/or size (e.g. ill thrift, stunted growth, weight loss) and pneumonia were the main reason 
for referral of cases to the SCPAHFS with a total of 164 and 147 affected animals 
respectively (9% of the total caseload for both categories). These were followed by Johne’s 
disease, which was an important condition in both cattle (97 animals) and sheep (41 animals) 
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and represented 8% of the total caseload. Ovine pulmonary adenocarcinoma (OPA) was the 
referral reason of 83 sheep cases, 5% of the total caseload. Dental or mandibular problems 
were also an important condition in sheep (70 animals) compared to cattle (3 animals). The 
rest of referral reasons represented less than 5% of the total 2006-15 SCPAHFS caseload. A 
table with the full list of individual referral reasons is presented in Appendix 10.  
 
 
Figure 3.17 Cattle and sheep referral reasons grouped by affected system as per the VIDA categories. Error 
bars denote binomial 95% confidence limits. 
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Referral reason Cattle Sheep Others1 Total Total %2 
Alterations of body weight and/or size 97 65 2 164 9 
Pneumonia 124 14 9 147 9 
Johne's disease 97 41 0 138 8 
OPA 0 83 0 83 5 
Dental/mandibular abnormalities 3 70 0 73 4 
Healthy animal 25 29 18 72 4 
Diagnosis not recorded 30 26 10 66 4 
BVD PI 64 0 0 64 4 
Diarrhoea 56 4 2 62 4 
Cull animal 6 36 11 53 3 
Displaced abomasum 51 0 0 51 3 
Lameness 26 19 0 45 3 
Pericarditis 43 0 0 43 2 
Mastitis 21 19 0 40 2 
Arthritis / Polyarthritis 18 17 3 38 2 
Congenital abnormalities 31 5 1 37 2 
Neurological deficits 18 16 2 36 2 
Peritonitis 29 1 0 30 2 
Endocarditis 26 1 0 27 2 
Others3  505 142 30 677 39 
Total 1,270 588 88 1,946 113 
Table 3.1 Individual referral reasons per species. 1Includes pigs, goats and alpacas. 2Over a total 
of 1,727 cases. Some animals presented with more than one referral reason, therefore the total 
percentage adds up to more than 100%. 3Conditions that represented less than 1% of the total 
cases were grouped under ‘Others’. 
 
 
3.3. Discussion 
 
This study was designed to analyse and describe the demographics and referral reasons of 
the 2006-15 SCPAHFS caseload, with the aim to provide a first evaluation of its suitability 
as an additional source of surveillance data. Data were available for summary and analysis 
from a substantial number of farm animals (1,727), predominantly cattle and sheep in South 
West and Central Scotland. The summary provides an interesting insight into the crude 
breakdown of health problems causing chronic conditions affecting economic productivity 
in cattle and sheep. The caseload covered an extensive area in Scotland and North West 
83 
  
 
 
 
England and overlapped with the DSC in Ayr and Dumfries, suggesting that the SCPAHFS 
could complement the surveillance activities in these areas.  
 
The study was based on the analysis of data recorded in a spreadsheet where many fields 
were missing and the existing records required a considerable amount of data cleaning. 
Currently, case information at SCPAHFS is recorded in three different locations, in different 
formats: a spreadsheet, paper case files and electronic case folders. The records are not 
integrated and none of the platforms collated all the information (e.g. the daily progression 
of the cases is only recorded on the cases’ paper file). A considerable amount of data are 
recorded at the SCPAHFS; however, these are not readily accessible. There may be some 
inaccuracies in the data presented in this study resulting from cases not recorded in the 
spreadsheet. In addition, although the spreadsheet includes a field to record post-mortem 
diagnoses, these were missing in more than 50% of the caseload, which is the reason why 
these were not analysed in this study. Another inconvenience was the lack of standardisation 
of the referral reasons that were recorded in a free-text field and included both clinical signs 
and diagnoses. For this thesis, these were grouped under the body system groups included 
in the VIDA report (Animal and Plant Health Agency, 2015c); however, the individual 
VIDA codes only include diagnoses and comparison between VIDA and the results of this 
study was not possible.  
 
To the author’s knowledge there are no previous reports of caseloads received by farm 
animal veterinary teaching hospitals and there is little literature about the most common 
conditions diagnosed by first opinion farm animal practitioners. A survey published by the 
University of Nottingham in 2014, in which UK  practitioners were asked what were the 
three most frequently seen conditions, found that reproductive disease was the most common 
condition both cattle and sheep were examined for, followed by respiratory, non-specific 
and musculoskeletal conditions (Nielsen et al., 2014). In Sweden, an analysis of data from 
the dairy industry cattle database also identified reproductive disorders as the most frequent 
(e.g. mastitis, puerperal paresis, retained placenta), followed by respiratory disease and 
gastrointestinal disorders (Mörk et al., 2009). Reproductive disease cases are usually dealt 
with by first opinion veterinary practitioners and treated on farm and are therefore rarely 
referred to the SCPAHFS (less than 10% of cases in cattle and sheep). However, both 
references highlighted digestive, respiratory and systemic diseases as important conditions 
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of cattle and sheep. These findings agree with the most common referral reasons presented 
by the SCPAHFS caseload.  
 
A degree of bias is always associated with any source of passive surveillance data, especially 
when these are not primarily obtained for surveillance purposes. Farm animal veterinary 
hospitals that receive animals that may be treated and sent back to the farm of origin are 
likely to receive higher proportions of specialised cases. Cases that are considered valuable 
enough to justify the expense of the treatment may also be over represented (Bartlett et al., 
2010). By contrast, the SCPAHFS relies on donated cases that do not return to the farm and, 
therefore, most animals are affected by chronic and endemic conditions, as shown by the 
results of this study. The literature suggests that the referral of cases or submission of 
samples to diagnostic laboratories is affected by the farm distance to the centre (Watson et 
al., 2008; Bartlett et al., 2010). This was also the case at the SCPAHFS, where the origin of 
the cases was dictated by the proximity to the centre, even though the free collection service 
is offered to all farmers regardless of their location. The relationship between first opinion 
veterinarians and laboratories has also been highlighted as an important component to ensure 
the quality of surveillance data (Robinson et al., 2012; The Scottish Government, 2011). At 
the SCPAHFS, practices that have a closer relationship with the centre have referred the 
most cases over the ten years – e.g. practitioners involved in Bachelor of Veterinary 
Medicine and Surgery (BVMS) teaching, practices where SCPAHFS staff have worked 
previously and vice versa. The feedback provided to the farmer and referring veterinarian by 
phone call and the summary letter also help to sustain these relationships.  
 
The denominator data for the total animal population at risk of disease, from which these 
cases were referred, is unknown. Furthermore, it is unknown what proportion of similar 
cases are not referred; therefore, estimation of the total burden of disease in the population 
is not possible with these data, though this also applies to VIDA and other surveillance data.  
 
In addition to the inevitable bias, surveillance data obtained from secondary sources is 
commonly affected by poor data completeness. This was the case in the recording in the 
National dairy databases used by the Scandinavian countries, where the usefulness of the 
data recorded in the systems in the different countries was poor due to data incompleteness 
(Lind et al., 2012). As discussed above, the SCPAHFS is affected by both factors. Although 
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a considerable amount of data are recorded at the centre, these are not readily available for 
analysis due to the different formats of recording.  
 
To summarise, this study highlighted the chronic and uneconomic nature of the cases 
received at the SCPAHFS, based on the referral reasons given by first opinion practitioners. 
Due to data incompleteness, the final diagnoses for the 2006-15 caseload were not analysed. 
It was therefore decided to perform a more detailed analysis of the 2015 caseload, as it was 
the most complete dataset. The results of this study are presented in Chapter 5 and include 
the final diagnoses reached at the SCPAHFS during that year. The latter are compared to the 
VIDA report, with the aim to allow a better evaluation of the potential usefulness of the 
SCPAHFS as an additional source of surveillance data.  
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4. Diagnoses reached at the SCPAHFS in 2015 
 
 
4.1. Introduction 
 
The main source of passive animal health surveillance in the United Kingdom is the post-
mortem (PM) examinations carried out at disease surveillance centres (DSC) and veterinary 
investigation (VI) laboratories. The latter are collated in the Veterinary Investigation 
Diagnosis Analysis (VIDA) database. The previous chapter has presented the characteristics 
of animals admitted to the SCPAHFS between 2006 and 2015. However, it has not analysed 
data regarding the diagnoses reached at the centre during the ten-year period. The aim of this 
study was to describe in more detail the demographics and diagnoses of the 2015 caseload 
and to compare the data to VIDA information so assess if the SCPAHFS could be useful as 
a complementary source of information for passive surveillance.  
 
 
4.2. Results 
 
 
4.2.1. Number of cases 
 
A total of 228 animals were referred to the SCPAHFS in 2015. The total number of cases 
admitted per species is shown in Figure 4.1. Only cattle, sheep and alpacas were admitted in 
2015, and the proportions were different from the total SCPAHFS 2006-15 caseload (Figure 
3.1, p < 0.05). When compared to the samples submitted per species to the VIDA database 
in 2014 (Figure 4.2) the distribution was also different (p < 0.05), with more cattle and other 
cases and fewer sheep in the VIDA database.  
 
Figure 4.3 shows the monthly admissions for cattle, sheep and total cases in 2015. Overall, 
March, August and October were the months with the most cases, with 27, 28 and 24 animals 
admitted respectively, whilst the months with the fewest cases were July, September and 
December, when only 13, 11 and 8 animals were admitted.  
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Figure 4.1 Number of cases admitted to the 
SCPAHFS in 2015. 
 
Figure 4.2 Number of samples submitted to the VIDA 
database in 2014 (Animal and Plant Health Agency, 
2015c). 1Includes pigs and goats. 
 
 
Figure 4.3 Monthly cases admitted to the SCPAHFS in 2015. 
 
Figures 4.4 and 4.5 show the age distributions of the 2015 SCPAHFS cattle caseload and the 
2015 Scottish cattle population, respectively. Cattle admitted to the SCPAHFS during 2015 
were younger than the overall age distribution of the 2006-15 cattle caseload (Chi-square 
test, p = 0.042). When compared using a Chi-square “goodness of fit” test, the age 
distribution of the SCPAHFS cattle differed from the Scottish 2015 cattle population (Chi-
square test, p = 0.0003). As observed with the overall 2006-15 caseload, the age distribution 
for dairy cattle was significantly older than the age distribution of beef cattle (Chi-square 
test, p = 0.011), as shown in Figures 4.6 and 4.7. In 2015 the age distribution of sheep 
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admitted to the SCPAHFS (Figure 4.8) was significantly younger than the overall 2006-15 
sheep age distribution (Figure 3.9, Chi-square test, p = 0.003), however it did not differ from 
the age distribution of sheep in Scottish holdings in June 2015 when considering those 
animals with a known age (Figure 4.9, Chi-square test, p = 0.1859). 
 
 
Figure 4.4 Age distribution of the 2015 SCPAHFS 
cattle caseload 
 
Figure 4.5 Age distribution of cattle in Scottish 
holdings in June 2015 (The Scottish Government, 
2016b). 
 
 
Figure 4.6 Age distribution of dairy cattle admitted to 
the SCPAHFS in 2015. 
 
Figure 4.7 Age distribution of beef cattle admitted to 
the SCPAHFS in 2015. 
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Figure 4.8 Age distribution of sheep admitted to the 
SCPAHFS in 2015. 
 
Figure 4.9 Age distribution of sheep in Scottish 
holdings in June 2015 (The Scottish Government, 
2016b). 
 
 
4.2.2. Origin of the cases 
 
The cases admitted in 2015 originated from 121 different farms and were referred from 29 
veterinary practices. The farms were located in 10 postal areas in Scotland and Northern 
England (Figure 4.10) and 3 postcodes, corresponding to 4 cases, were missing.  During 
2015 the postal areas with more referred cases were G (47 animals), ML (45 animals), DG 
(34 animals) and PA (28 animals). In comparison to the overall 2006-15 caseload less cases 
were admitted from KA (23 animals). Therefore there was less overlap with the area covered 
by the DSC in Ayr. 
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Figure 4.10 Total cases referred per postal area in 2015 and location of the respective referring veterinary 
practices and SRUC DSC.  
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4.2.3. Length of stay at the SCPAHFS 
 
Figure 4.11 shows how long after being admitted to the SCPAHFS the animals were 
examined at post-mortem. The majority of the cases (58%) were euthanased within a week 
of their admission.   
 
 
Figure 4.11 Length of stay at the SCPAHFS of the animals admitted in 2015. 
 
 
4.2.4. Referral reasons 
 
The distribution of referral reasons for cases admitted to the SCPAHFS in 2015 was very 
similar to the overall for the 2006-15 caseload (Figure 4.12). Figure 4.13 shows the referral 
reasons for cattle and sheep admitted in 2015, grouped by affected system. The main 
individual referral reasons (≥ 2% of the caseload) are summarised in Table 4.1. 
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Figure 4.12 Comparison between the referral reasons grouped by affected system for the total 2006-15 
caseload (blue) and the 2015 cases (orange). Error bars denote binomial 95% confidence limits. 
 
 
Figure 4.13 Proportion of cattle and sheep referral reasons in 2015, grouped by affected system. Error bars 
denote binomial 95% confidence limits. 
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Referral reason Cattle  Sheep Alpacas Total Total %1 
Alterations of body weight and/or size 14 14 0 28 12 
Pneumonia 23 1 0 24 11 
OPA 0 18 0 18 8 
Johne's disease 13 3 0 16 7 
Arthritis, Polyarthritis 3 8 0 11 5 
BVD PI 8 0 0 8 4 
Bloating 6 0 0 6 3 
Congenital abnormalities 5 1 0 6 3 
Diagnosis not reached (Systemic disease) 3 3 0 6 3 
Heart murmur 6 0 0 6 3 
Diarrhoea 4 1 0 5 2 
Healthy animal 2 3 0 5 2 
Infertility 0 5 0 5 2 
Pericarditis 5 0 0 5 2 
Heart failure 4 0 0 4 2 
Mastitis 3 1 0 4 2 
Poor recovery after surgery 4 0 0 4 2 
Others2 56 16 2 74 32 
Grand Total 159 74 2 235 103 
Table 4.1 Summary of individual referring reasons for cases admitted to the SCPAHFS in 2015. 1Over a total 
of 228 cases. Some animals presented with more than one referral reason, therefore the total percentage adds 
up to more than 100%.  2Those that represented less than 2% of the total 2015 caseload are grouped under 
‘Others’. 
 
 
4.2.5. Final diagnoses 
 
Figure 4.14 summarises the final diagnoses reached at the SCPAHFS during 2015 for cattle 
and sheep, compared to the 2014 VIDA diagnoses, both grouped by affected system. For 
152 cattle admitted in 2015, 216 diagnoses were reached (142%), whereas 74 sheep cases 
presented 110 diagnoses (149%). The individual diagnoses compared to the equivalent 
VIDA code are presented in Figures 4.15 for cattle and 4.16 for sheep. 
 
Focusing on the cattle caseload, ‘diagnosis not reached’ was the main category in the VIDA 
report, with 49% of the cases not having a diagnosis (14,238 samples). By contrast, at the 
SCPAHFS the proportion of cases that did not have a final diagnosis was substantially lower, 
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with only 8% of the animals without a final diagnosis (14 animals). There was also a 
difference between the clinical conditions diagnosed by both systems. At the SCPAHFS 
diseases affecting the digestive system were the main category, representing 58% of the 
cases (88 animals) and respiratory disease was the second most common diagnosis, reached 
in 29% of the cases (44 animals). By contrast, in the 2014 VIDA report, reproductive disease 
was the most frequent diagnosis, with 29% of the cases affected (8,524 samples) followed 
by digestive disease, with 23% of the cases (6,646 samples). At the SCPAHFS reproductive 
and mammary disease accounted for the final diagnosis of only 8% of the cases admitted in 
2015.  
 
For the 2015 SCPAHFS sheep caseload, digestive and respiratory diseases were also the 
main final diagnoses reached at the SCPAHFS, representing 47% (35 animals) and 43% (32 
animals) of the cases, respectively. In the 2014 VIDA report, reproductive disease was again 
the main diagnosis in sheep (23%, 1,891 samples), followed by digestive disease (21%, 
1,724 samples). However, ‘diagnosis not reached’ was still the first category in the VIDA 
sheep caseload (35%, 2,873 samples), whereas at the SCPAHFS only 9% of sheep cases did 
not have a final diagnosis (7 animals). At the SCPAHFS there was 1 sheep (1%) for which 
no information was available regarding clinical diagnosis or laboratory submissions and the 
post-mortem report was missing. This animal was euthanased on the same day as its 
admission and the case file was blank.  
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Figure 4.14 Proportion of diagnoses reached at the SCPAHFS in 2015 for cattle and sheep cases, compared 
to the VIDA cattle diagnoses in 2014, grouped by affected system. Error bars denote binomial 95% confidence 
limits.  
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Figure 4.15 Individual final diagnoses reached at the SCPAHFS in cattle in 2015, and proportions for the 
same diagnoses in the 2014 VIDA cattle report. Error bars denote binomial 95% confidence limits. 
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Figure 4.16 Individual final diagnoses reached at the SCPAHFS in sheep in 2015, and proportions for the 
same diagnoses in the 2014 VIDA sheep report. Error bars denote binomial 95% confidence limits. 
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4.3. Discussion 
 
This study provided a more detailed analysis of the 2015 SCPAHFS caseload, including the 
final pathological diagnoses reached at the centre during that year, and compared them to 
the VIDA report, with the aim to evaluate the usefulness of the SCPAHFS caseload as an 
additional source of surveillance data. 
 
The 2015 caseload was chosen for this study as it was the most complete dataset in the 
original MS Office Excel spreadsheet. In 2015, there was a small variation in the proportion 
of cases admitted per species at the SCPAHFS – only two alpacas were admitted and the rest 
of cases were cattle (67%) and sheep (32%), and the age distribution of the cases admitted 
in 2015 was younger than the 2006-16 overall. However, the referral reasons were 
representative of the 2006-15 caseload. The data had to be compared to the 2014 VIDA 
report as, at the time of analysing the data for this study, 2015 VIDA data had not yet been 
published. Additionally, it was considered appropriate to compare the data to the 2014 report 
since the changes in the delivery of surveillance in England and Wales the incorporation of 
additional PM providers and triage of samples are likely to be reflected in the 2015 VIDA 
results.  
 
The diagnoses reached at the SCPAHFS during 2015 were classified following the VIDA 
report codes. However, with the SCPAHFS caseload it was found that many diagnoses did 
not have an equivalent code in the VIDA report and had to be grouped under ‘diagnosis not 
listed’. The codes used in this study were extracted from the report and not the original VIDA 
database. Some of the conditions may have had a code but were not diagnosed in VIDA 
samples hence did not appear in the report, although others may simply not be included in 
the database. This indicates that the SCPAHFS caseload may represent a population of cases 
that are not currently captured under a specific VIDA category. By categorising conditions, 
however, there can be issues with diagnoses being assigned to the wrong category if clear 
definitions are not provided. If data from the SCPAHFS caseload were to be used for 
surveillance purposes, there is a need to improve the recording methods, collating all the 
information under one system and using unified nomenclature and diagnoses. Of course, this 
would also require quality assurance and standardisation of PM diagnoses reached by 
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pathologists in SCPAHFS and DSC and VI centres. This would be easily achievable, and 
the pathologists employed at the School of Veterinary Medicine are highly qualified.  
 
Comparisons between passive surveillance sources are always difficult since data are 
different by nature. Passive surveillance data are always affected by biases that vary between 
sources. This study found clear differences between the SCPAHFS and VIDA caseloads. 
Diseases of the reproductive and mammary systems were the main condition reported to 
DSC and VI laboratories. This is likely to be due to compulsory reporting of cattle abortions 
as part of the surveillance strategy for brucellosis (Department for Environment and Animal 
and Plant Health Agency, 2014); such cases are not referred to the SCPAHFS. Farmers and 
first opinion practitioners are more likely to submit samples to DSC and VI centres when 
animals are valuable and a diagnosis has not been reached, especially if the condition affects 
multiple individuals and causes high losses (Watson et al., 2008; Animal and Plant Health 
Agency, 2014d). By contrast, animals admitted to the SCPAHFS usually have a low value 
and are affected usually by chronic and endemic conditions. ‘Diagnosis not reached’ (DNR) 
cases are an important proportion of the VIDA caseload. Emphasis is put on these as they 
could offer insight into the emergence of new conditions (Hyder et al., 2011). However, 
VIDA DNR cases are often due to limited diagnostic value of the samples submitted to the 
laboratories (Gibbens et al., 2008; Watson et al., 2008). The SCPAHFS is set up in such a 
way that multiple diagnostic tests can be performed in the live animal and almost every case 
undergoes a post-mortem examination. Therefore, it is expected to reach a diagnosis in the 
majority of cases. However, the causative agents are often not identified at the SCPAHFS 
(e.g. bacterial agents in cases of pneumonia or arthritis). This is limited by the fact that the 
centre covers the costs of the PM examination but additional testing derived from PM 
findings has to be paid by the farmer. As these cases are often worth very little to the farmer, 
diagnostics beyond the gross PM are rarely performed. Additionally, the chronic nature of 
most cases also limits the diagnostic value of the samples, i.e. infections are no longer active.  
 
No previous studies have been published that present the caseload and diagnoses reached at 
farm animal veterinary practices or teaching hospitals. However, the conditions diagnosed 
in sheep admitted to the SCPAHFS were similar to the diagnoses reported by a study that 
examined sheep at fallen stock collection centres (Lovatt and Strugnell, 2013). Apart from 
mastitis, which was the most frequent condition, that study reported pneumonia in 13% of 
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the cases, OPA in 6%, Johne’s disease in 6% and neoplasia in another 6% of the examined 
sheep. Cases admitted to the SCPAHFS are affected by chronic and uneconomic conditions, 
similar to those collected by fallen stock services. The latter receive diseased animals that 
die or are euthanased on farm and are not submitted for PM examinations at DSC or VI 
centres, either because the animal was not valuable enough, because the pathology was 
diagnosed by the farmer or it was not perceived as a flock/herd problem. Compared to fallen 
stock centres, the SCPAHFS caseload presents the advantage that the infrastructure to 
perform tests in the live animal and PM examinations is already in place. Using data from 
centres like the SCPAHFS would complement the diagnoses reached at DSC and VI centres, 
identifying chronic or endemic conditions that may otherwise be missed and offering some 
insight into their changing presentation over time, especially in the event of a national control 
plan, such as the Scottish BVD Eradication Scheme (see Chapters 5 and 6).   
 
In summary, results of this study have shown that the SCPAHFS caseload covers a 
proportion of the Scottish sheep and cattle caseload that is not currently included in the 
existing surveillance system. The data generated at the SCPAHFS have the potential to 
complement surveillance activities in Scotland, although improved and unified data 
recording methods are needed. The next chapter provides an example of how additional 
information from the cases admitted to the SCPAHFS can contribute to monitor changes in 
endemic conditions in Scotland. Persistent infection with BVD virus was the reason for 
referral of 6% of the total 2006-15 SCPAHFS caseload. The interest for bovine viral 
diarrhoea (BVD) is increasing in Europe, with many countries making efforts to eradicate 
the disease (Stahl and Alenius, 2012; The Scottish Government, 2015a). With the Scottish 
BVD eradication scheme entering its fourth stage in June 2015 it was decided to evaluate 
whether the SCPAHFS caseload could provide evidence of any changes in the presentation 
of BVD PI cattle that may have happened as a consequence of the launch of the Scottish 
BVD eradication scheme.  
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5. Progression of the clinical presentation of BVDV PI 
cattle at the SCPAHFS in relation to the launch of the 
Scottish BVD Eradication Scheme 
 
 
5.1. Introduction 
 
The previous two chapters have introduced the Scottish Centre for Production Animal Health 
and Food Safety (SCPAHFS) caseload, presented the demographics of the donated 
population of cases, the most common reasons for referral and the conditions diagnosed at 
the centre. This information has been compared to VIDA data in order to ascertain the 
similarities and differences between the two data sets. The data generated at the SCPAHFS 
often provide more information than that required to make a diagnosis and provide feedback 
to the farmer and referring veterinary surgeon. Some of these data have been used in various 
other studies and case reports. Cardiac disease cases were used in a study that evaluated the 
clinicopathological differences between cases of pericarditis, endocarditis and congenital 
heart disease (Bexiga et al., 2008). Cases have also been used to compare the differential 
diagnosis of bluetongue, mucosal disease and malignant catarrhal fever (MCF) (Bexiga et 
al., 2007). More recently, a study has analysed the characteristics of the neurological disease 
caseload presented at the SCPAHFS (article submitted for publication). Various reports of 
unusual conditions diagnosed at the SCPAHFS can also be found in the literature (Hannon 
et al., 2014; Gladden et al., 2015).  However, to date, bovine viral diarrhoea (BVD) cases 
have not been reported in such a way.  
 
In Scotland, the BVD Eradication Scheme is making progress; however, over 470 confirmed 
persistently infected (PI) cattle are still alive (J. Purcell, personal communication). Currently, 
PI animals cannot be moved to other farms but only sent to slaughter, with an exception: by 
applying for a special movement licence PI cattle can be admitted to the SCPAHFS to be 
used as teaching cases. As PI animals are worth very little to the farmer and pose a serious 
threat in the maintenance of BVD virus (BVDV) within a cattle population (Lindberg and 
Houe, 2005) the SCPAHFS is a useful option for farmers and veterinarians when trying to 
dispose of these animals. In one of the previous studies it was identified that between 2006 
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and 2015, 73 animals were admitted to the SCPAHFS for PI with BVDV or mucosal disease 
(MD), 6% of the total cattle caseload (Chapter 3). As BVDV is at the forefront of farmer’s 
and veterinarians’ minds, given the implementation of the eradication scheme, the aim of 
this study was to analyse the PI case load before and after the scheme and to evaluate any 
changes that may have occurred as a consequence of the implementation of the Scottish 
Government BVD Eradication Scheme.  
 
 
5.2. Results 
 
 
5.2.1. Bovine viral diarrhoea virus antigen and antibody results 
 
Table 5.1 summarises the cases that were investigated as part of this study as discussed in 
the Material and Methods section (Chapter 2). A total of 91 cases were identified as being 
potential cases for this study. Five cases had missing case files (5%), two cases had not been 
tested for antigen (2%) and 11 were antigen negative (12%), therefore 73 cases remained as 
having positive antigen results (80%). Further analysis of these 73 cases found that 17 were 
only tested once at SCPAHFS for BVDV antigen (23%), three animals were tested twice but 
less than 21 days apart (4%) and one animal was tested twice but the second antigen result 
was negative (1%). These were also excluded from the study. Finally, there was a case that 
originated from England and this was also dismissed since the farm was not affected by the 
Scottish BVD Eradication Scheme. A total of 51 animals were defined as BVDV PI and 
included in this study. These represent 1% of the total PI cattle identified between the start 
of the scheme and August 2016 (J. Purcell, personal communication). Of the animals that 
were tested for BVDV antigen at the SCPAHFS, three tested positive for antibody (BVDV 
antibody p80 ELISA).  
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Referral reason or post-mortem 
diagnosis 
Ag +ve Ag -ve 
Not 
tested 
Missing Total 
BVD or BVD PI 53 10 1 4 68 
Mucosal disease 11 0 0 0 11 
Cerebellar hypoplasia 0 1 1 1 3 
Others 9 N/A N/A N/A 9 
Total 73 11 2 5 91 
Table 5.1 Summary of case files searched for BVDV antigen positive results and those that had negative or 
missing results or that were not tested. Highlighted in yellow are the cases that were selected for the study. 
Later, 22 out of 73 were also excluded from the analysis. 
 
 
5.2.2. Case signalment 
 
Of the total 51 BVD PI cases, 25 were admitted before the start of the BVD Eradication 
Scheme (January 2006 – August 2010) and 26 after (September 2010 – December 2015). 
Figure 5.1 shows the number of cases admitted per year. The year with most cases was 2009, 
with 11 BVD PIs admitted that year. The only year without cases was 2011 and two PIs were 
admitted in 2010, one in May and one in August, and therefore both were classified as ‘pre-
scheme’ cases.  
 
 
Figure 5.1 Number of BVD PIs admitted per year in relation to the start of the Eradication 
Scheme (orange before, blue after). Two animals were admitted in 2010, one in May and one 
in August, and therefore both fall under the ‘pre-scheme’ category. 
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Figure 5.2 shows the signalment (beef or dairy, sex and age group) of the BVD PIs admitted 
before and after the start of the Eradication Scheme. The majority of BVD PIs originated 
from beef farms, both before and after the scheme, although there was an apparent increase 
in dairy cases after 2010 (no significant difference, Chi-square test, p = 0.242). No 
differences (Chi-square test, p = 0.925) were observed in the proportion of female and male 
cases admitted before or after the scheme, with female cases being nearly 70% of the 
admissions. Regarding the ages of the BVD PIs, although the difference was not significant 
(Chi-square test, p = 0.057), BVD PIs presented at the SCPAHFS tended to be younger 
(under one year old) after the start of the Scheme. The median age of animals admitted before 
the start of the scheme was 12 months old (range from four months old to four years and 
three months old), whereas the median age of animals admitted after the scheme started was 
6 months old (range from one month old to two years and 11 months old). 
 
 
Figure 5.2 Case signalment before and after the start of the eradication scheme. Number of beef, dairy, 
female, male and age distribution of the BVD PI cattle included in the study. Error bars denote binomial 95% 
confidence limits.  
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5.2.3. Origin of the cases 
 
Figure 5.4 shows the total cases referred per postal area and the location of the referring 
veterinary practices. Figures 5.4 and 5.5 show the distribution of cases and practices before 
and after the start of the scheme, respectively. No postcodes were missing for the cases’ 
farms of origin and only one referring practice could not be located. Cases originated from 
Central and South-West Scotland and, as with the 2006-15 SCPAHFS caseload (section 
3.2.2), postal areas adjacent to Glasgow referred the most cases. A total of 16 different 
veterinary practices referred BVD PI cases between 2006 and 2015 and the animals 
originated from 32 farms. Of the practices, six referred cases only before the Scheme, seven 
only after the Scheme had started and three referred cases during both stages. There were no 
farms that sent cases both before and after the Scheme started – 15 farms referred cases 
before and 17 after.  
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Figure 5.3 Total number of BVD PI cases referred per postal area and location of their referring veterinary 
practices. 
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Figure 5.4 Number of BVD PI cases referred per postal area before the start of the Eradication Scheme and 
location of their referring veterinary practices. 
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Figure 5.5 Number of BVD PI cases referred per postal area after the start of the Eradication Scheme and 
location of their referring veterinary practices. 
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5.2.4. History 
 
In the history taken from the farmer, before the start of the scheme, ten farmers did not mention 
BVD and one history was blank (Figure 5.6). During the scheme only two farmers did not 
mention BVD (Figure 5.7). Looking at the veterinarian history, two referring veterinarians did 
not mention BVD before the scheme (one blank history) (Figure 5.8). One of them was referred 
as a suspected case of Johne’s disease and the second one as a case of pericarditis. After the 
scheme, the referring veterinarian did not mention BVD in two cases (Figure 5.9) that were twin 
calves referred for coccidiosis. In this case, the farmer mentioned BVD, but in relation to 
previous diseases on farm: he was not expecting these animals to be PI, and both were tested 
twice at the SCPAHFS.  
 
Figures 5.10 to 5.13 show the number of cases that the farmer or referring veterinary practitioner 
mentioned clinical signs before and after the scheme. The proportions of farmers that mentioned 
signs were similar both before and after the start of the scheme. No significant differences were 
found in the number of veterinarians that reported clinical signs (Chi-square test, p = 0.266), 
although an apparently smaller proportion of animals were referred with signs after the start of 
the scheme. The individual signs mentioned by the farmer and veterinarian are summarised in 
Figures 5.14 and 5.15 (diagnoses of Johne’s disease, pericarditis and coccidiosis not included). 
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Figure 5.6 Number of cases in which the 
farmer mentioned BVD or not in the history 
before the start of the Eradication Scheme. 
 
Figure 5.7 Number of cases in which the 
farmer mentioned BVD or not in the history 
after the Eradication Scheme started. 
 
 
Figure 5.8 Number of cases that the referring 
veterinarian mentioned BVD in the history 
before the start of the Eradication Scheme. 
 
Figure 5.9 Number of cases that the referring 
veterinarian mentioned BVD in the history after 
the start of the Eradication Scheme. 
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Figure 5.10 Number of cases that the farmer 
reported clinical signs in the history before the 
start of the Scheme. 
 
 
Figure 5.11 Number of cases that the farmer 
reported clinical signs in the history after the 
start of the Scheme. 
 
Figure 5.12 Number of cases that the 
veterinarian reported in the history before the 
start of the Scheme. 
 
 
Figure 5.13 Number of cases that the 
veterinarian reported clinical signs in the 
history after the start of the Scheme. 
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Figure 5.14 Other clinical signs reported by the farmer before and after the start of the 
Eradication Scheme. Error bars denote binomial 95% confidence limits. 
 
 
Figure 5.15 Other clinical signs reported by the referring veterinary practitioner before and after 
the start of the Eradication Scheme. Error bars denote binomial 95% confidence limits. 
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5.2.5. Clinical presentation 
 
Figure 5.16 and Figure 5.17 show the number of cases that were presented with clinical signs 
or had no clinical signs on the first full clinical examination at the SCPAHFS. The majority of 
BVD PIs admitted before the start of the scheme presented with clinical signs, while after the 
scheme the majority had no detectable clinical signs (Chi-square test, p = 0.036). The clinical 
signs diagnosed at the SCPAHFS are presented in Figure 5.18. Respiratory disease was the main 
clinical finding and there were eight cases of mucosal disease diagnosed before the start of the 
scheme, but none after. 
 
 
Figure 5.16 Number of cases presented with 
clinical signs on the first clinical examination 
before the start of the scheme. 
 
Figure 5.17 Number of cases presented with 
clinical signs on the first clinical examination 
after the start of the scheme. 
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Figure 5.18 Proportion of main clinical signs detected on the first clinical examination of BVD 
PIs admitted before (Pre) and after (Post) the start of the Eradication Scheme. Error bars 
denote binomial 95% confidence limits. 
 
 
5.2.6. Post-mortem diagnoses 
 
Figure 5.19 summarises the number of cases that had abnormal findings on the post-mortem 
(PM) examination, those that had no significant findings and those that were missing a post-
mortem report, before and after the start of the BVD eradication scheme. Surprisingly, more 
animals presented gross PM findings after the start of the scheme than before. Figure 5.20 
presents all the individual PM diagnoses reached in the BVD PI cases. Bronchopneumonia was 
the main finding in both stages, present in 32% of the BVD PI animals admitted before the 
scheme started and 69% after. Mucosal disease was only diagnosed in cases admitted before the 
scheme started (eight animals, 32%). There was one case admitted before (4%) and five after 
(19%) that presented a minor degree of gastrointestinal ulceration on the PM examination, 
without associated MD. There were more cases with no significant gross post-mortem findings 
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before (8 animals, 32%) than after (4 animals, 15%) but also more animals were missing a post-
mortem report before (3 animals, 12%) than after (1 animal, 4%).  
 
 
Figure 5.19 Findings on the post-mortem examination of cases admitted before and 
after the start of the eradication scheme. Error bars denote binomial 95% confidence 
limits. 
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Figure 5.20 Proportion of post-mortem findings reached before (pre) and after (post) the start of the Eradication 
Scheme (*No Associated Disease). Error bars denote binomial 95% confidence limits. 
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5.3. Discussion 
 
This study was designed to evaluate any changes in the clinical presentation of BVDV PI cattle 
that may have occurred as a consequence of the launch of the Scottish BVD eradication scheme. 
Since the scheme started, the prevalence of Scottish herds classed as not-negative for  BVDV 
has decreased from 40% in 2010 to 12% in 2015 (Carty and Caldow, 2016) and by August 2016 
over 4,700 PI animals had been identified in total, 472 of which were still alive (J. Purcell, 
personal communication, August 2016). The year with most BVDV PI animals admitted to the 
SCPAHFS was 2009, before the start of the scheme, with 11 cases. This increase was due to 
one of the farms that the SCPAHFS works with controlling the disease during that year. Six PI 
calves were identified and referred to the SCPAHFS. The farm has since then been BVD 
negative. In 2010, the two PIs admitted that year were referred before the start of the Scheme in 
September and none were admitted during 2011. However, since 2012, the year the scheme 
became compulsory, the number of cases admitted has been constant (six or seven animals per 
year), which is consistent with farmers identifying and removing animals. After the application 
of the latest control measures and the removal of the bulk tank milk (BTM) test options in 2014, 
the number of PIs identified per year has increased from 742 in 2014, to 1,479 in 2015 (J. 
Purcell, personal communication). This increase in the number of PIs identified did not result 
in more cases being admitted at the SCPAHFS in 2015. However, given the existing movement 
restrictions on BVD PI and untested cattle and the fact that first opinion veterinary practitioners 
and farmers may not be aware of the possibility of sending PI cattle to the SCPAHFS, may have 
affected the number of cases being referred to the centre.  
 
Cattle PI with BVDV admitted to the SCPAHFS originated from South-West of Scotland, one 
of the regions with the highest percentage of not-negative herds (The Scottish Government, 
2016d). The fact that farmers referred cases to the SCPAHFS either before or after the start of 
the scheme but not in both periods is likely to be consistent with regional progress made with 
the control scheme. For example, the Ayrshire (KA postal area) and Lanarkshire (ML) have 
gone from over 35% and 28-35% of not-negative herds in 2013 to 22-27% and 7-9% in 2015, 
respectively (The Scottish Government, 2016d). 
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The majority of PI cattle in this study originated from beef herds, which agrees with the 
observation that the disease is being controlled faster in beef than dairy farms. In 2011, after the 
first stage of the Scottish eradication scheme, it was calculated that 52% of Scottish dairy herds 
were exposed to the virus, as opposed to 23% of beef herds and, by September 2015, the 
proportions had decreased to 31 and 9% respectively (Carty and Caldow, 2016). This represents 
a reduction of 40% of exposed dairy herds and 61% of beef. Evidence has shown that farmers 
take longer to initiate further investigations when a positive antibody result is obtained from a 
milk sample rather than blood (Duncan et al., 2016). In addition, dairy farmers seem to rely 
more on vaccines to control BVD than beef farmers (Cowley et al., 2012), which may interfere 
with BVD investigations. Therefore, beef farmers are likely to be faster in identifying and 
removing PI cattle, sending more cases to the SCPAHFS.  
 
Animals admitted to the SCPAHFS after the start of the eradication scheme tended to be younger 
than those admitted before. Although the difference was not statistically significant, this is likely 
to be due to the low number of cases in the study. This finding indicates that, as a consequence 
of compulsory testing, BVDV PI cattle are being identified and removed faster, resulting in less 
chances to transmit the virus. At the same time, younger BVD PIs will have had less chances to 
suffer immunosuppressive effects of the infection, presenting less clinical disease as shown by 
the reduction in the number of animals that presented with clinical disease after the start of the 
scheme. This is supported by the fact that first opinion veterinary practitioners reported fewer 
clinical signs in the history of animals referred after the start of the scheme and this group of 
cases presented less clinical disease on admission at the SCPAHFS. By contrast, there were no 
differences in the percentage of farmers that mentioned clinical signs in the history of cases 
admitted before or after the scheme. Farmers may be inclined to report clinical signs if they feel 
that they need to report disease for the animals to be accepted for admission to the SCPAHFS, 
when this is not the case. Ill thrift was the most common clinical sign reported in the animals’ 
history both before and after the scheme started. This is consistent with the evidence that PI 
animals can present slow growth rates and be more susceptible to secondary diseases, resulting 
in poorer performance than uninfected cattle (Taylor et al., 1997; Stokstad and Løken, 2002). In 
this study, the body condition and growth rates of the animals were not evaluated given the 
different breeds and ages of the animals and the fact that body condition scores (BCS) and 
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weights were not consistently recorded on the cases’ clinical examination forms. However, a 
considerable proportion of BVD PIs were clinically normal. Of those that presented clinical 
signs respiratory disease was the most common diagnosis, being more frequent in cases admitted 
before the scheme started (52% before and 23% after). In contrast, bronchopneumonia was 
reported on PM examination of more cases admitted after the scheme (32% before, 69% after). 
This result, however, may be affected by a lack of consistency in the format of PM reports 
during the years included in this study. In addition to the fact that more PM reports were missing 
in cases admitted before the scheme started, it was found that prior to 2009 the results of PM 
examinations were often handwritten on the animal’s case file by the SCPAHFS clinician or the 
pathologist on duty and they only included the main PM finding. This is also reflected in the 
number of individual PM diagnoses identified in both periods (Figure 5.26). There was a wider 
variety of pathologies recorded after the start of the scheme (7 before, 18 after). Secondary 
conditions like bronchopneumonia were likely to be underreported in cases admitted before the 
scheme started in 2010. Secondary pathologies may have been present, however, these may 
have been deemed not relevant and were not consistently recorded in the PM reports of animals 
admitted before 2009.  
 
Respiratory pathology was present in 23% to 69% of the BVD PIs admitted during the whole 
length of the study. This finding is consistent with studies that have highlighted the increased 
predisposition towards respiratory disease in animals infected with BVDV (Bolin, 2002). A 
study that followed the clinical progression of 28 BVD PI calves found that 25% of them 
presented gross pneumonic lesions at PM as the only significant pathology (Taylor et al., 1997). 
In a more recent study that analysed the clinical presentation of BVD PI cattle admitted to a 
clinic for ruminants of the University of Zurich, respiratory disease was present in 63% of the 
animals (Bachofen et al., 2010). The same study reported that the most common clinical signs 
mentioned by the farmer in the cases’ history were diarrhoea (41%), pneumonia (20%) or both 
(9%) and neurological signs (10%). At the SCPAHFS, diarrhoea was more frequently reported 
as a clinical sign than pneumonia and, although congenital neurological malformations have 
been reported in cattle PI with BVDV (Otter et al., 2009),  none of the PIs in this study were 
reported to have neurological disease in the history or were diagnosed with neurological disease 
at the time of clinical examination. Two of the PIs admitted to the SCPAHFS presented with 
120 
 
 
 
 
cataracts, an abnormality that has been associated with congenital BVDV infection (Agerholm 
et al., 2015). 
 
The results of this study may be interpreted to suggest that the eradication scheme has resulted 
in an obvious improvement in awareness about BVD amongst farmers, as shown by the increase 
in the number of farmers that mentioned BVD in the history of cases admitted after the scheme 
started (56% before, 92% after). However, following the implementation of the first control 
measures whereby movements were restricted, SCPAHFS clinicians were required to ask about 
the farm´s BVD status which may have been a factor in the apparent increased awareness 
amongst farmers. Referring veterinary practitioners mentioned the disease in most cases both 
before and after the scheme, which indicates that the veterinary profession had a good awareness 
of the disease. However, before the scheme started three cases that were diagnosed with MD at 
the SCPAHFS were initially referred as Johne’s disease (paratuberculosis) and coccidiosis 
cases. As eradication programmes make progress and severe disease associated with BVD 
decreases, veterinary practitioners will need to remain aware of the clinical presentation of MD, 
which could resemble other important ulcerative conditions (e.g. malignant catarrhal fever, foot-
and-mouth disease) some of which are notifiable (Taylor et al., 1994; Holliman, 2005; Bexiga 
et al., 2007). 
 
Diagnosis of PI with BVDV in this study was based on evidence of two positive antigen results 
in samples taken at least 21 days apart and/or a confirmed diagnosis of MD at post-mortem. All 
the animals diagnosed with MD tested positive for antigen at the SCPAHFS, but none were re-
tested at the centre and only four out of eight had been tested on farm. It may have been the case 
that animals at the SCPAHFS were euthanased before a second sample could be collected. The 
lesions presented at post-mortem were consistent with MD, but it is still a possibility that these 
animals were not PI but transiently infected (TI) animals affected by severe acute presentations 
of the disease (Liebler-Tenorio et al., 2003). A final MD diagnosis would have required isolation 
of the cytopathic (cp) BVDV strain from the affected animals. Bachofen et al. (2010) isolated 
cp-BVDV from MD cases and associated the results with a ‘mucosal index’, calculated based 
on the number of organs that presented mucosal ulceration at PM, and established a threshold 
to identify MD using the index. This calculation was not possible in this study given that some 
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PM reports only included a final diagnosis. As this study was based on retrospective data, this 
could not be performed; however, this highlights the importance of case definitions and 
following diagnostic protocols if data are to be used for research or surveillance purposes.  
 
To summarise, the results of this study indicate that BVD PIs in Scotland are being identified 
and removed from farms at earlier stages of disease, reducing the risk of transmission of the 
virus. Younger PI cattle have less chances to succumb to secondary disease and be exposed to 
cp-BVDV strains and therefore present with less clinical disease. As eradication schemes 
progress and the population of cattle susceptible to BVDV expands, the potential costs of 
missing BVDV cases increases and veterinary practitioners cannot rely on the clinical 
presentation of the disease to detect incursions anymore. This is highlighted in the following 
and last study of this thesis, which presents the case of a farm BVD outbreak that was detected 
due to the compulsory testing of the eradication scheme. 
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6. Bovine Viral Diarrhoea Farm Case Study 
 
 
6.1. Introduction 
 
The aim of any national eradication scheme is to reduce the impact that a disease has on a 
region’s farming industry, in terms of animal health, welfare and its economy. Case studies are 
a useful method to analyse the effect that certain measures have at the farm level, as well as to 
understand the farmer’s perceptions about the eradication scheme. During the collection of data 
for the bovine viral diarrhoea (BVD) study, five cases referred from the same farm in a period 
of just over a year were identified. In the history of the first case, it was mentioned that the 
animal was the first BVD virus (BVDV) persistently infected (PI) calf found in the herd. 
Additionally, the tests that enabled detection of the outbreak were performed due to the 
compulsory, second stage of the Scottish BVD Eradication Scheme. A meeting was arranged 
with the farmer and his/her first opinion veterinarian, with the aim to reconstruct the events, 
analyse the costs and outcomes of the outbreak and present the farmer’s perceptions.  
 
 
6.2. Farm history  
 
Located in south west Scotland, the farm is divided into two units: 156 acres located at the home 
farm and 540 acres in a new farm acquired in 2010. The owners traditionally kept a flock of 600 
Scottish Blackface breeding ewes at the home farm. In October 2010, the new farm was acquired 
through a leasing contract and a cattle herd was started with 27 cows. By 2012 the herd size had 
increased to 50-60 cattle and in 2015 the numbers reached 111 cows. No stock were kept at the 
new farm prior to the farmer renting it and the initial herd was mainly Aberdeen Angus cross 
cows and pregnant heifers sourced from different markets in Scotland. Two bulls, a two-year 
old Aberdeen Angus and a two-year, two-month old Simmental were also acquired at the time 
from a BVDV accredited breeder. The last stock were bought in in 2013 and since 2014 the 
farm has been relying on homebred heifers for replacements. The long term plan is to only buy 
123 
 
 
 
 
in bulls and have 100 breeding cows and 25 to 30 bulling heifers coming into the herd each year. 
Currently, replacement heifers and ewe lambs are reared at the home farm and then moved to 
the new farm in time for mating. In the long term, the aim is to rear and breed the heifer 
replacements at the home farm and then send them to the new farm as in calf heifers. 
 
There are two farms neighbouring the home farm and two farms neighbouring the new farm. At 
the home farm, animals have nose-to-nose contact across the boundary fences with both 
neighbours. Contact with a third potential neighbour is separated by a road. At the new farm, 
electric fences were put in place in addition to the boundary fences to prevent contact with 
neighbouring stock. Confirmation of the BVD status of all the neighbours is unknown, although 
it is thought that all the herds in contact with the new farm are currently BVD negative based 
on mandatory tests as per the Scottish BVD eradication scheme.  
 
All lambing and calving takes place at the new farm. Calving currently extends from January 
until the middle of April. Lambing takes place in March. Cows are typically out-wintered but 
housed four to six weeks prior to calving. Once the dam has calved and the calf has established 
a bond with its mother they are turned out to grass, assuming that the weather is favourable. 
Calves are given access to creep feed 12 weeks prior to sale in the store market. 
 
By December 2015 the farmer owned three bulls. A fourth bull was sold recently, after his fifth 
breeding season and there are plans to buy a new replacement soon. The farmer has been using 
the same accredited breeder since he bought the first two bulls.  
 
 
6.3. The outbreak 
 
The BVD outbreak on this farm is summarised in a timeline in Figure 6.1 in relation to the 
progression of the Scottish BVD eradication scheme. The first BVD test performed on this farm 
was in March 2012 to fulfil the requirements of the second stage of the Scottish BVD 
Eradication Scheme. No tests were performed during the initial stage of the scheme (September 
2010 – April 2011), when screening was voluntary but subsidised. The chosen testing method 
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was the calf check test. A group of 13 heifers between 9 and 18 months old were tested for 
antibody (blood antigen capture enzyme-linked immunosorbent assays (ACE)), which was more 
than the required five animals from a single management group (The Scottish Government, 
2014). These were home-bred heifers, weaned at the new farm in October 2011 and moved to 
the home farm in March 2012, when they were tested. Out of these 13 animals, one tested 
positive for antibodies to BVDV. Following the advice of the veterinary surgeon at the time, in 
September 2012 all calves were tested for BVDV antigen (blood reverse transcription 
polymerase chain reaction (RT-PCR)) to try to identify a PI. This test was delayed to fit with 
the farmer’s management schedule. A month before the September follow-up test was 
performed, seven cows with calves at foot had been purchased. The farm of origin of these 
animals had already performed an antibody check test BVD test under the Scottish eradication 
scheme. However, the bought-in calves were tested with the rest of the calves and a PI calf was 
found within the bought-in group. Cows were given a presumed BVD antigen negative status if 
their calves tested negative. After finding the first PI, the affected calf and its dam were isolated. 
They were brought to the home farm and kept at grass in a small paddock with access to shelter 
and straw bedding.  No follow-up bloods were performed on the calf as it was ill thriven and 
was showing clinical signs of being persistently infected with BVD, while the dam tested 
negative for antigen. This calf was treated on farm for pneumonia, initially with long-acting 
oxytetracycline and later with florfenicol, without improvement and was referred to the Scottish 
Centre for Production Animal Health and Food Safety (SCPAHFS) on 3rd October 2012. Blood 
samples were taken on admission of the animal and the PI status of the calf was confirmed on 
antigen testing. 
 
The farm started following a BVD vaccination protocol in October 2012 with the use of an 
inactivated vaccine (Bovilis ® MSD Animal Health). It was acknowledged that the timing of 
this vaccination was not as per datasheet recommendations (primary course completed no less 
than four weeks before the start of gestation) but the first opinion veterinarian was worried about 
compliance with the vaccination protocols if the vaccine was to be administered during the 
summer grazing period. Since 2013 all replacement heifers receive a primary immunisation in 
January with a second dose four weeks later to ensure that protection is given well before the 
entry of the bulls in April. At the same time cows receive a booster. Boosters are given in 
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October only to those cows and heifers scanned in calf. Non-pregnant cows are sold and bulls 
are not vaccinated. The farm also planned to test all calves born in 2013 for antigen with tissue 
tags, which is a practice that has continued thereafter. 
 
During the 2013 season, there was one abortion; however, no diagnostic work-up was performed 
and therefore this could not be definitively attributed to BVD. In the same season, six antigen 
positive calves were identified on tissue testing, but no follow-up tests were performed to 
confirm their PI status (they were assumed to be PIs). As with the first PI identified in 2012, in 
2013 all PIs and their dams were isolated at the home farm. These dams were not tested since 
they had antigen-negative calves the previous season and were assumed negative. Two out of 
this group of six PIs were admitted to the SCPAHFS in March and May 2013, when they were 
two and six weeks old respectively. There were no records of BVD tests for the calf admitted in 
March at the SCPAHFS. The calf referred in May tested antigen positive on blood taken on 
admission. The farmer made the decision to keep two of the other PI calves in isolation at the 
home farm. These were animals that looked ´normal´ and were growing well. In an attempt to 
get them to slaughter weight, the farmer took them off their mothers and hand-reared them. They 
continued to thrive until one developed pneumonia, at which point they both rapidly 
deteriorated. The farmer attempted treatment with penicillin and observed a slight improvement, 
but the pneumonia relapsed a month later. These two animals were referred to the SCPAHFS in 
October 2013, at six months of age. Both animals were tested for BVD on admission at the 
SCPAHFS and were confirmed antigen positive. The remaining two of the six calves that tested 
antigen positive died on farm.  
 
As of 2013, all bought-in female stock and calves at foot were isolated and tested for BVDV 
antigen prior to mixing with the herd. A total of 40 bulling and in-calf heifers were bought in 
that year, all of which were found to be free of BVDV. After this point, the farmer decided not 
to buy in any more stock apart from breeding bulls. Currently, the farmer relies on the bull 
breeder’s BVDV test and the bulls are not isolated. 
 
In 2014, all calves continued to be tissue tag tested. Two calves tested positive for BVD, one of 
which was born from one of the 2013 bought in in-calf heifers. These two calves were re-tested 
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on blood and subsequently found to be BVD negative. The farm achieved a BVD negative status 
in the same year and has maintained it since then. In 2015, all calves were tissue tag negative. 
The farmer had hoped to be able to stop tissue-testing all the calves and rely solely on the check 
test. However, discussion with his veterinarian has convinced him to continue tissue testing, 
especially considering the potential risks of expanding the herd and having increased contact 
with neighbours at the home farm. 
 
 
 
 
 
127 
 
 
 
 
 
Figure 6.1 Timeline of the BVD outbreak at the farm in comparison with the progression of the Scottish BVD Eradication Scheme.
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6.4. Herd health impact of the outbreak 
 
No herd health issues were appreciated in the herd by the farmer during the BVD outbreak. They 
were happy with the percentage of cows confirmed in calf. There was no record of weak or 
stillborn calves and no increases in calf losses were detected. Table 6.1 summarises the number 
of cows put to the bull, the percentage of barren cows and the percentage of reared calves for 
2011-15 in relation to the targets recommended by Fertbench, the suckler herd fertility 
benchmarking service offered by the Scottish Agricultural College (SAC) Consulting (Quality 
Meat Scotland, 2010). In the season that BVDV was introduced to the farm (2012-13), the seven 
lost calves corresponded to the seven BVD PIs identified on farm. In 2014-15 there was an 
increase in the percentage of barren cows, a decrease in the number of calves reared to sale point 
and more cases of calf diarrhoea. However, given that BVD had been eradicated from the farm, 
these were not investigated further. The farmer did observe that PI calves were prone to 
pneumonia. In addition, the farmer mentioned that if he/she had not kept the two ‘healthy’ PI 
calves and tried to rear them, only for them to deteriorate, they may subsequently have struggled 
with the concept of culling an animal just because it is a PI.  
 
 Farm values Target2 
Calving season 2011-12 
2012-
131 
2013-14 2014-15 Top 
Bottom 
quarter 
Average 
Number of cows put to 
the bull 
65 68 116 128    
Number of cows and 
heifers scanned in calf 
59 64 107 110    
Barren cows (%) 9 6 8 14 ≤ 5   
Calves reared (%) 80 84 85 77 93 79 88 
Table 6.1 Summary of pregnancy rates and calf losses per season from 2011 to 2014. 1Year of the BVD outbreak. 
2(Quality Meat Scotland, 2010)  
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6.5. The cost of the outbreak 
 
The biggest cost of the BVD outbreak on this farm was considered to be associated with culling 
of PI animals. The farmer estimated the overall cost at £7,600. This includes loss of stock, testing 
of animals and labour, but does not include the cost of adding electric fences at the new farm, 
the extra bedding, feed and work of keeping animals isolated. Currently, the farm is spending 
around £650 a year in the continued testing of calves and £490 in vaccines, which results in 
£10.40 per cow per year in a 110 cow herd. 
 
 
6.6. Farmer perceptions 
 
Regarding BVD understanding, the farmer mentioned that prior to the BVD outbreak they 
he/she was aware of the acronym but had no understanding of what it was or what it meant. This 
was partially due to the farm historically being a sheep flock, but also because they had no 
previous experience with the disease. Information about BVD came from the farm’s veterinary 
practitioners, speaking to fellow producers and articles in the farming press. When asked if 
he/she considered having a BVD negative herd status represented a benefit when selling 
animals, the overall feeling was that there was minimal interest from the store market as to BVD 
status. The farmer’s perception is that the market’s primary focus is on pneumonia. No breeding 
heifers were sold while the farm had a non-negative status. However, the general comment was 
that a non-negative status made no difference to the sale value in the industry. 
 
 
6.7. Discussion 
 
Case studies in relation to the control of BVD have been published before. In a series of 
interviews published on the Scottish Government’s website (The Scottish Government, 2013a), 
the experiences of six farmers were presented. In most cases, the interviewed farmers were 
aware of BVD before the Eradication Scheme started, mainly due to participation in Health 
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Schemes or disease investigations. Similarly, Animal Health Ireland (Animal Health Ireland, 
2016) interviewed four farmers who had made efforts to eradicate BVD in their herds before the 
national Irish programme was launched in 2012. By contrast, the farm presented in this study 
only initiated testing for BVD when it was required by the Scottish BVD Eradication Scheme 
and the farmer was not aware of the disease prior to this testing. Case studies presented by the 
Scottish Government and AHI reported that farmers noted poor growth rates in calves, increased 
susceptibility to infection, greater mortality and reduced fertility. The farmer in this study 
noticed that PI animals were more susceptible to respiratory disease, which is recognised as one 
of the main complications of BVDV infection (Ridpath, 2010). However, the outbreak had little 
perceived effect on the overall herd’s productivity. In the year of the BVD outbreak the 
percentages of barren cows and reared calves were not worse than in other years. Overall, the 
farm values are between the bottom quarter and the average Scottish beef suckler herd, 
according to Quality Meat Scotland data (Quality Meat Scotland, 2010). Worse rates were 
observed in this herd in 2014-15. These, in addition to BVD, can be affected by a multitude of 
factors and were not investigated further. The consequences of BVDV infection in a herd depend 
on the virus strain involved, the herd organisation and the animals’ immune status (Gates, 
Humphry, et al., 2013). The fact that, due to compulsory testing, PI calves were quickly detected, 
isolated and removed from the herd was key for the success of controlling BVD in this herd.  
 
Buying animals into a herd from external untested sources has been recognised as one of the 
main risks for introduction of BVD to a herd (Graham et al., 2013), and the risk is higher when 
the introduced animals are cows with calves at foot or pregnant dams (Gates et al., 2014). This 
was the route of introduction of the first PI in this herd. What is interesting about this outbreak 
is that the group of 13 heifers with the initial positive check result in March 2012 did not have 
contact with the calf that was subsequently identified as a PI (this calf didn’t arrive on farm until 
August 2012). The source of the antibody positive result in the 2012 check test was not 
confirmed. It remains a possibility that the animal seroconverted after being transiently infected 
by nose-to-nose contact with infected neighbouring cattle indicating another potential source of 
virus over and above bought-in animals (Ersbøll et al., 2010; Graham et al., 2016). To avoid this 
contact, electric fences were added to the existing boundary fences at the new farm, where adult 
cattle and calves are kept most of the time. At the home farm, the farmer is now keeping pregnant 
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heifers away from fields that have contact with neighbour’s cattle. The circumstances of the 
check test performed at the farm of origin of the bought-in PI are unknown. However, it is 
important to emphasize the fact that when performing antibody check tests, it is essential to 
correctly identify and sample separate management groups. Otherwise there is risk to miss 
antibody positive animals and the source of infection.  
 
Following the identification of antigen positive animals from the calf screen test in September 
2012 and the instigation of tag testing all calves in 2013, antigen positive animals were 
identified. This case study indicated that many of these antigen positive animals were only tested 
for antigen once.  Given that a single antigen detection test cannot differentiate between 
transiently infected (TI) or PI animals (Dubovi, 2013), follow-up tests are recommended for 
each antigen positive result, at least three weeks after the initial sample (Lanyon et al., 2014; 
The Scottish Government, 2015b). These were only performed on five out of the seven antigen-
positive calves (on farm or at the SCPAHFS). Therefore, it remains a possibility that the 
remaining two calves were not persistently but only transiently infected due to exposure to 
comingling PI calves. Animals TI can also successfully transmit BVDV (Lindberg and Houe, 
2005); however, it is not necessary to remove them from the herd in an eradication programme. 
Removing TI animals as a result of inadequate testing would result in farmers losing money in 
terms of unnecessary culling of animals. At this farm, since 2014, all the calves are tag tested 
and follow-up blood tests are performed when required. After eradicating BVDV from a herd, 
monitoring is essential to react against new incursions of the virus (Lindberg and Houe, 2005) 
and although tag testing all the calves may have higher associated costs than antibody check 
tests, it allows faster detection of BVDV in the herd and has a higher cost-benefit margin 
(Santman-Berends et al., 2015).  
 
The brief cost analysis in this study was based on the farmer’s estimates; therefore, the cost is 
likely to be inaccurate but allows some comparisons with values published in the literature. The 
cost of the present outbreak was estimated as £7,600 (£126.67 per cow, herd of 60 cows) in one 
year and the farmer is currently spending £1,140 in monitoring and vaccinating for BVDV. This 
estimate is higher than those reported in the Scottish Government case studies, where the costs 
due to losses and control of the outbreaks ranged between £1,010 to £4,317 for a 150 cattle beef 
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herd (£6.31 and £28.78 per animal respectively) (The Scottish Government, 2013b; The Scottish 
Government, 2013c), although the scenarios presented were mainly based on farms endemically 
infected with BVD. Regarding the cost of continuous monitoring and control measures for the 
disease, prior to launching the Eradication Scheme, the Scottish Government estimated the costs 
of controlling BVD in the first year of the Scheme in £1,629 for a Less Favoured Area (LFA) 
cattle and sheep farm (The Scottish Government, 2010a), which is a higher value compared to 
the annual £1,140 spent at the present farm. The latter represents a cost of £10.40 per cow per 
year for a herd of 110 cows. In 2004, the losses associated with BVD in an endemic Scottish 
beef suckler herd were calculated at £37 per cow per year (Gunn et al., 2004). Compared to this 
value, the present farm could be considered to be saving £26.60 per cow per year in BVD-
associated losses compared to a herd in which the disease is uncontrolled. 
 
This case study confirms the importance of many issues in relation to the control of BVD. These 
include the implementation of a national eradication programme to raise farmer’s awareness of 
the disease, appropriate follow-up testing of antigen positive animals, prompt removal of PI 
animals and implementation of appropriate biosecurity, vaccination and on-going monitoring 
measures. Had the PI animals on this farm not been identified (in response to further testing 
required by the Scottish Government BVD eradication scheme) the impact of the disease could 
have been much greater for the health, welfare and productivity of this farming enterprise.  
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7. General discussion 
 
Animal health surveillance is an essential activity that helps to protect animal health and welfare, 
public health and international trade and the economy. New threats to animal and human health 
have been a constant in history and will continue to emerge; therefore, surveillance systems 
need to constantly adapt to this changing environment. To ensure that systems are efficient and 
fit for purpose, reviews and evaluations of surveillance activities are becoming more frequent. 
In the United Kingdom (UK) the entire veterinary surveillance strategy was reconsidered after 
the 2001 Foot-and-mouth (FMD) outbreak (Department for Environment Food and Rural 
Affairs, 2003) and this devolved in later reviews of the provision of surveillance in England and 
Wales and Scotland. The final report of the review of veterinary surveillance – ‘The Kinnaird 
Report’, was published by the Scottish Government in 2011. The document recognised the need 
for more cost-effective approaches to surveillance and recommended the inclusion of existing 
animal health data streams in the existing system. In this context, this thesis aimed to evaluate 
the usefulness of the Scottish Centre for Production Animal Health and Food Safety 
(SCPAHFS) caseload as a source of passive surveillance data.  
 
Passively obtained surveillance data always come with a degree of bias, especially if data are 
not primarily collected for surveillance purposes (Sorensen et al., 1996). Samples are more 
likely to be submitted to the Veterinary Investigation Diagnosis Analysis (VIDA), the main 
passive surveillance system in the UK, when diseases cause acute signs, cause higher losses in 
the herd or flock and animals are valuable enough to pay for the testing (Watson et al., 2008; 
Animal and Plant Health Agency, 2014d). In the case of the SCPAHFS, the caseload is biased 
towards chronic and uneconomic cases, given the way the clinic is organised. Clear structural 
differences exist between VIDA and the SCPAHFS and the results of the second study strongly 
suggested that the SCPAHFS caseload represents a part of the livestock population that is not 
currently captured by VIDA. In addition, the caseload covered similar regions to the Scotland’s 
Rural College (SRUC) Ayr and Dumfries DSCs. Therefore, the SCPAHFS could complement 
surveillance activities in these regions. The number of cases received at the centre is smaller 
than the samples submitted to DSC or VI centres; however, information from these cases would 
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otherwise be missed. Due to their low economic value, animals referred to the SCPAHFS would 
otherwise be collected by fallen stock services and, since post-mortem examinations are not 
routinely performed at these centres, their information would be missed (Lovatt and Strugnell, 
2013). Additionally, given that the SCPAHFS caseload is already used for teaching and research 
purposes, this represents a cost-effective source.  
 
The relationship between the SCPAHFS and the first opinion farm animal practitioners is very 
important to guarantee the flow of cases into the centre. Clinicians at the SCPAHFS make sure 
that feedback on the cases is given to both farmers and veterinarians, by phone call and a 
summary letter posted to the veterinarian. However, a regular report or summary of the cases 
received at the SCPAHFS is not currently being produced. Publishing this type of report would 
be beneficial to referring farmers and practitioners and would provide additional information on 
the endemic conditions that affect livestock in their regions. 
 
Regardless of whether or not a final diagnosis was reached, each case admitted to the SCPAHFS 
generates clinical data that could be used for research and surveillance purposes. Examples of 
conditions that have been studied using the SCPAHFS caseload include cardiac disease in cattle, 
bluetongue, malignant catarrhal fever and mucosal disease and kangaroo gait in ewes (Clements 
et al., 2002; Bexiga et al., 2007; Bexiga et al., 2008). The third study in this thesis was designed 
with the aim of making use of the additional information generated by the SCPAHFS caseload, 
with emphasis on bovine viral diarrhoea (BVD). Due to its economic impact, BVD is currently 
the focus of control programmes in several European countries (Volker Moennig et al., 2005; 
Stahl and Alenius, 2012). In Scotland the BVD Eradication Scheme was launched in 2010 and 
since then over 4,700 PI animals have been identified. Analysis of the clinical presentation of 
BVD PIs admitted to the SCPAHFS over the last ten years has shown that cases admitted after 
the eradication scheme started tended to be younger and presented less clinical disease, 
indicating that PIs are being detected and removed at earlier stages in disease, reducing the 
chances to transmit the virus. These findings highlight some of the elements of success of the 
eradication scheme. As the scheme progresses and the levels of circulating BVD virus decrease, 
identifying BVD infection based on clinical findings will no longer be viable. Detecting 
infection will become more difficult and the risks associated with missing infected animals will 
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increase, which emphasises the importance of carrying out active surveillance for the disease, 
as exemplified by the case study. 
 
A common issue in the three first studies was the lack of standardisation and incompleteness of 
the data recorded in the original spreadsheets. These are some of the most common constraints 
to adding data from secondary sources to surveillance systems (Lind et al., 2012; Velasova et 
al., 2015). Data cleaning was a big part of the data collation process for these studies. The 
information that the spreadsheets missed is available; however, the lack of coordination between 
three different recording systems that are in different formats (paper and electronic records) 
makes the process of collating data more time consuming, which was the reason why the final 
diagnoses reached at the SCPAHFS were only analysed in the second study. The main 
improvement needed at the SCPAHFS to make the most of the data generated by the caseload 
is the instigation of a new recording system. This would need to use pre-populated fields, with 
standardised nomenclature that minimises common typing mistakes with free-text entry.  
 
There is potential to study the clinical presentation of many other conditions referred to the 
SCPAHFS (e.g. ovine pulmonary adenocarcinoma and Johne’s disease). The use of improved 
recording methods would facilitate this research. Keeping the animals’ case files in electronic 
records would also make the task of publishing a regular report on the conditions diagnosed at 
the centre much easier.  
 
The SCPAHFS is a source of animal health data that has potential to provide information for 
surveillance purposes, with emphasis on endemic and chronic conditions in cattle and sheep 
from Central and South West Scotland. However, the existing data collation and recording 
methods need to be improved.  
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Appendix 2: Farmer consent form 
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Appendix 3: Case labels 
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Appendix 4: Clinical examination form
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Appendix 5: Clinical progression (TPR) sheets
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Appendix 6: Additional results form
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Appendix 7: Communication record form 
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Appendix 8: Example of biochemistry and haematology results 
 
148 
 
 
 
 
 
149 
 
 
 
 
Appendix 9: Example of post-mortem report 
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Appendix 10: Referral reasons of the 2006-15 caseload 
 
Referral Reason Cattle Sheep Pigs Alpacas Goats Total Total % 
Affections of body weight and/or 
size 
97 65 2 0 0 164 8.4 
Pneumonia 124 14 9 0 0 147 7.6 
Johne's disease 97 41 0 0 0 138 7.1 
OPA 0 83 0 0 0 83 4.3 
Denta or mandibular 
abnormalities 
3 70 0 0 0 73 3.8 
Healthy animal 25 29 18 0 0 72 3.7 
Diagnosis not recorded 30 26 10 0 0 66 3.4 
BVD PI 64 0 0 0 0 64 3.3 
Diarrhoea 56 4 2 0 0 62 3.2 
Cull animal 6 36 11 0 0 53 2.7 
Displaced abomasum 51 0 0 0 0 51 2.6 
Lameness 26 19 0 0 0 45 2.3 
Pericarditis 43 0 0 0 0 43 2.2 
Mastitis 21 19 0 0 0 40 2.1 
Arthritis, Polyarthritis 18 17 3 0 0 38 2.0 
Congenital abnormalities 31 5 1 0 0 37 1.9 
Neurological deficits 18 16 2 0 0 36 1.8 
Peritonitis 29 1 0 0 0 30 1.5 
Endocarditis 26 1 0 0 0 27 1.4 
Traumatic 
reticulopericarditis/peritonitis 
(Wire disease) 
21 0 0 0 0 21 1.1 
Spastic paresis 19 0 0 0 0 19 1.0 
Metritis, Endometritis, Pyometra 16 2 0 0 0 18 0.9 
Pre-96 animal 18 0 0 0 0 18 0.9 
Bloating 15 1 0 0 0 16 0.8 
Lymphoma, Lymphosarcoma 16 0 0 0 0 16 0.8 
Heart failure 15 0 0 0 0 15 0.8 
Heart murmur 14 1 0 0 0 15 0.8 
Malignant catarrhal fever 14 0 0 0 0 14 0.7 
Fracture 5 7 1 0 0 13 0.7 
Liver fluke 7 6 0 0 0 13 0.7 
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Referral Reason Cattle Sheep Pigs Alpacas Goats Total Total % 
Portocaval thromboembolism 13 0 0 0 0 13 0.7 
Hernias - Umbilical 9 0 3 0 0 12 0.6 
Infertility 2 9 1 0 0 12 0.6 
Abscessation 10 1 0 0 0 11 0.6 
Laryngeal chondritis, Laryngitis 4 7 0 0 0 11 0.6 
Poor recovery after surgery 11 0 0 0 0 11 0.6 
Pyelonephritis 11 0 0 0 0 11 0.6 
Spinal abscess or trauma 3 8 0 0 0 11 0.6 
Cataracts 9 1 0 0 0 10 0.5 
Abomasal ulceration 7 0 1 1 0 9 0.5 
Ascites, Oedema 8 1 0 0 0 9 0.5 
Mucosal disease 9 0 0 0 0 9 0.5 
Trauma 6 3 0 0 0 9 0.5 
Chondrodystrophia 8 0 0 0 0 8 0.4 
Diagnosis not reached 
(Respiratory system) 
5 3 0 0 0 8 0.4 
Hernias - Scrotal 1 1 6 0 0 8 0.4 
Listeriosis 5 3 0 0 0 8 0.4 
Milk yield drop 8 0 0 0 0 8 0.4 
Anorexia 5 2 0 0 0 7 0.4 
Gastrointestinal parasitism 1 3 0 0 3 7 0.4 
IBR 7 0 0 0 0 7 0.4 
Blindness 3 3 0 0 0 6 0.3 
Border Disease  0 6 0 0 0 6 0.3 
Diagnosis not reached 
(Systemic disease) 
3 3 0 0 0 6 0.3 
Pica, Tail biting 0 0 6 0 0 6 0.3 
Poisioning - Bracken 1 5 0 0 0 6 0.3 
Udder abnormalities 1 5 0 0 0 6 0.3 
Hip luxation 4 1 0 0 0 5 0.3 
Neoplasia 5 0 0 0 0 5 0.3 
Nephritis 5 0 0 0 0 5 0.3 
Pain 5 0 0 0 0 5 0.3 
Testicular abnormalities 0 5 0 0 0 5 0.3 
Abortion 2 2 0 0 0 4 0.2 
Actinomycosis (Lumpy jaw) 4 0 0 0 0 4 0.2 
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Referral Reason Cattle Sheep Pigs Alpacas Goats Total Total % 
Cerebellar lesions 4 0 0 0 0 4 0.2 
Diagnosis not reached (Skin 
disease) 
3 1 0 0 0 4 0.2 
Femoral nerve paralysis 4 0 0 0 0 4 0.2 
Footrot 1 3 0 0 0 4 0.2 
Liver abscesses 4 0 0 0 0 4 0.2 
Omphalitis 4 0 0 0 0 4 0.2 
Sudden death 3 1 0 0 0 4 0.2 
Swellings, lumps or masses 3 1 0 0 0 4 0.2 
Actinobacillosis (Wooden 
tongue) 
3 0 0 0 0 3 0.2 
Anaemia 1 2 0 0 0 3 0.2 
Atresia ani 3 0 0 0 0 3 0.2 
Caecal dilation 3 0 0 0 0 3 0.2 
Cerebrocortical necrosis 0 3 0 0 0 3 0.2 
Corneal ulceration 0 2 0 1 0 3 0.2 
Enteritis 3 0 0 0 0 3 0.2 
Freemartinism 3 0 0 0 0 3 0.2 
Gangliosis 0 3 0 0 0 3 0.2 
Infectious keratoconjunctivitis 
(Pink eye) 
1 2 0 0 0 3 0.2 
Lungworm 2 1 0 0 0 3 0.2 
Mediastinal mass 2 1 0 0 0 3 0.2 
Mesenteric or intestinal torsion 3 0 0 0 0 3 0.2 
Phlebitis 3 0 0 0 0 3 0.2 
Photosensitisation 2 1 0 0 0 3 0.2 
Renal amyloidosis 3 0 0 0 0 3 0.2 
Salmonellosis 3 0 0 0 0 3 0.2 
Sinusitis 3 0 0 0 0 3 0.2 
Urinary abnormalities, infection 3 0 0 0 0 3 0.2 
Uterine torsion 3 0 0 0 0 3 0.2 
Vagal indigestion 3 0 0 0 0 3 0.2 
Ventricular septal defect 3 0 0 0 0 3 0.2 
Abdominal mass 2 0 0 0 0 2 0.1 
Baldness 2 0 0 0 0 2 0.1 
BVD 2 0 0 0 0 2 0.1 
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Referral Reason Cattle Sheep Pigs Alpacas Goats Total Total % 
Closantel toxicity 0 2 0 0 0 2 0.1 
CNS lesion 1 1 0 0 0 2 0.1 
Coccidiosis 2 0 0 0 0 2 0.1 
Copper deficiency (Swayback) 0 2 0 0 0 2 0.1 
Depressed animal 2 0 0 0 0 2 0.1 
Drenching gun or bolus injuries 1 1 0 0 0 2 0.1 
Emphysema 2 0 0 0 0 2 0.1 
Facial nerve deficits 2 0 0 0 0 2 0.1 
Fibrosed udder 0 2 0 0 0 2 0.1 
Fistula 2 0 0 0 0 2 0.1 
Hermaphrodite 0 2 0 0 0 2 0.1 
Hydrocephalus 2 0 0 0 0 2 0.1 
Jaundice 1 1 0 0 0 2 0.1 
Liver failure 2 0 0 0 0 2 0.1 
Nystagmus 2 0 0 0 0 2 0.1 
Ocular abnormalities 1 1 0 0 0 2 0.1 
Oral ulceration 2 0 0 0 0 2 0.1 
Osteomyelitis 0 2 0 0 0 2 0.1 
Papillomatosis 2 0 0 0 0 2 0.1 
Persistent urachus 2 0 0 0 0 2 0.1 
Poisioning 2 0 0 0 0 2 0.1 
Pyrexia 2 0 0 0 0 2 0.1 
Regurgitation 1 0 1 0 0 2 0.1 
Retained foetal membranes 2 0 0 0 0 2 0.1 
Robotic gait, Kangaroo gait 1 1 0 0 0 2 0.1 
Ruminal acidosis 2 0 0 0 0 2 0.1 
Ruminal stasis 2 0 0 0 0 2 0.1 
Sole ulcer 2 0 0 0 0 2 0.1 
Swayback 0 2 0 0 0 2 0.1 
Umbilical abscess 2 0 0 0 0 2 0.1 
Urethral rupture 2 0 0 0 0 2 0.1 
Urolithiasis 2 0 0 0 0 2 0.1 
URT abnormalites 1 1 0 0 0 2 0.1 
Vaginal discharge or bleeding 2 0 0 0 0 2 0.1 
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Referral Reason Cattle Sheep Pigs Alpacas Goats Total Total % 
Vein distension 2 0 0 0 0 2 0.1 
Wobbler syndrome 0 2 0 0 0 2 0.1 
Brisket mass 1 0 0 0 0 1 0.1 
Clostridial enterotoxaemia 0 0 0 0 1 1 0.1 
Constipation 1 0 0 0 0 1 0.1 
Digital dermatitis 1 0 0 0 0 1 0.1 
Dropping cud 0 1 0 0 0 1 0.1 
Epistaxis 1 0 0 0 0 1 0.1 
Fatty liver 1 0 0 0 0 1 0.1 
Flaccid paralysis 0 1 0 0 0 1 0.1 
Foot granuloma 0 1 0 0 0 1 0.1 
Foreign body 0 1 0 0 0 1 0.1 
Haematoma 1 0 0 0 0 1 0.1 
Hemiparesis 1 0 0 0 0 1 0.1 
Hernias 0 0 1 0 0 1 0.1 
Hernias - Perineal 1 0 0 0 0 1 0.1 
Hypersalivation 1 0 0 0 0 1 0.1 
Interdigital dermatitis 0 1 0 0 0 1 0.1 
Leptospirosis 1 0 0 0 0 1 0.1 
Luxation 0 1 0 0 0 1 0.1 
Macerated foetus 1 0 0 0 0 1 0.1 
Melena 0 1 0 0 0 1 0.1 
Meningitis, Encephalitis 1 0 0 0 0 1 0.1 
Muscular atrophy 1 0 0 0 0 1 0.1 
Nephrosclerosis 1 0 0 0 0 1 0.1 
Nerve paralysis 1 0 0 0 0 1 0.1 
Opistothonos 1 0 0 0 0 1 0.1 
Orchitis 0 1 0 0 0 1 0.1 
ORF 0 1 0 0 0 1 0.1 
Osteochondritis dissecans 1 0 0 0 0 1 0.1 
Otitis 0 0 1 0 0 1 0.1 
Paraparesis 1 0 0 0 0 1 0.1 
Plantigrade gait 1 0 0 0 0 1 0.1 
Poisioning - Acorn/Oak 1 0 0 0 0 1 0.1 
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Referral Reason Cattle Sheep Pigs Alpacas Goats Total Total % 
Poisioning - Ragwort 1 0 0 0 0 1 0.1 
Polymelia 1 0 0 0 0 1 0.1 
Prolapsed nictitating membrane 1 0 0 0 0 1 0.1 
Protein-calorie malnutrition, 
Inappropriate diet 
0 1 0 0 0 1 0.1 
Protoporphyria 1 0 0 0 0 1 0.1 
Pyoderma 1 0 0 0 0 1 0.1 
Rectal or Anal stricture 0 0 1 0 0 1 0.1 
Renal abscessation 1 0 0 0 0 1 0.1 
Ringworm 1 0 0 0 0 1 0.1 
Rumen fluke 1 0 0 0 0 1 0.1 
Scoliosis / Kyphosis 1 0 0 0 0 1 0.1 
Seizures 1 0 0 0 0 1 0.1 
Septicaemia 1 0 0 0 0 1 0.1 
Seroma 1 0 0 0 0 1 0.1 
Skin disease 0 0 0 1 0 1 0.1 
Stiffness 1 0 0 0 0 1 0.1 
Stillbirth 0 1 0 0 0 1 0.1 
Tendon abnormality 1 0 0 0 0 1 0.1 
Tetanus 1 0 0 0 0 1 0.1 
Vaginal prolapse 1 0 0 0 0 1 0.1 
Vaginal tear 1 0 0 0 0 1 0.1 
Varicocele 0 1 0 0 0 1 0.1 
White muscle disease 0 0 0 1 0 1 0.1 
Total 1,270 588 80 4 4 1,946 100 
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